HRP20040717A2 - N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials - Google Patents
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials Download PDFInfo
- Publication number
- HRP20040717A2 HRP20040717A2 HR20040717A HRP20040717A HRP20040717A2 HR P20040717 A2 HRP20040717 A2 HR P20040717A2 HR 20040717 A HR20040717 A HR 20040717A HR P20040717 A HRP20040717 A HR P20040717A HR P20040717 A2 HRP20040717 A2 HR P20040717A2
- Authority
- HR
- Croatia
- Prior art keywords
- oxo
- oxazolidinecarboxamide
- alkyl
- dihydro
- methyl
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title description 6
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 349
- -1 -OH Chemical group 0.000 claims description 186
- 238000000034 method Methods 0.000 claims description 168
- 125000000623 heterocyclic group Chemical group 0.000 claims description 97
- 125000000217 alkyl group Chemical group 0.000 claims description 91
- 229910052736 halogen Inorganic materials 0.000 claims description 91
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 88
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 80
- 150000002367 halogens Chemical class 0.000 claims description 66
- 125000003118 aryl group Chemical group 0.000 claims description 63
- 229910052739 hydrogen Inorganic materials 0.000 claims description 56
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 43
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 42
- 229910052757 nitrogen Inorganic materials 0.000 claims description 42
- 238000011282 treatment Methods 0.000 claims description 42
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 39
- 229910052717 sulfur Inorganic materials 0.000 claims description 36
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 34
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 34
- 125000003545 alkoxy group Chemical group 0.000 claims description 31
- 125000001424 substituent group Chemical group 0.000 claims description 31
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 30
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 30
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 30
- 125000005843 halogen group Chemical group 0.000 claims description 26
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 claims description 23
- 125000002252 acyl group Chemical group 0.000 claims description 22
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 21
- 229920006395 saturated elastomer Polymers 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 18
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 18
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 16
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 15
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 15
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 14
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 14
- 125000003107 substituted aryl group Chemical group 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 12
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- JCSCLHOUNBXMEE-CYBMUJFWSA-N (5r)-3-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1=CCSCC1 JCSCLHOUNBXMEE-CYBMUJFWSA-N 0.000 claims description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 10
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
- 125000004076 pyridyl group Chemical group 0.000 claims description 10
- 125000004429 atom Chemical group 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 125000005842 heteroatom Chemical group 0.000 claims description 9
- 125000005942 tetrahydropyridyl group Chemical group 0.000 claims description 9
- ZTAAKFXBCMVLOG-LLVKDONJSA-N (5r)-3-(3,5-difluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1CCSCC1 ZTAAKFXBCMVLOG-LLVKDONJSA-N 0.000 claims description 8
- GCXVBAMUDDGHGW-GFCCVEGCSA-N (5r)-3-(3,5-difluoro-4-thiomorpholin-4-ylphenyl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1N1CCSCC1 GCXVBAMUDDGHGW-GFCCVEGCSA-N 0.000 claims description 8
- FQPPEKCCNRMKBJ-GFCCVEGCSA-N (5r)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCSCC1 FQPPEKCCNRMKBJ-GFCCVEGCSA-N 0.000 claims description 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 8
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 8
- 125000002393 azetidinyl group Chemical group 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- 239000003937 drug carrier Substances 0.000 claims description 7
- 125000002757 morpholinyl group Chemical group 0.000 claims description 7
- 125000004193 piperazinyl group Chemical group 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 125000004434 sulfur atom Chemical group 0.000 claims description 7
- WXYYFVRFZOIINO-GFCCVEGCSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCOCC1 WXYYFVRFZOIINO-GFCCVEGCSA-N 0.000 claims description 6
- ZXECHFBZDGVJIM-SNVBAGLBSA-N (5r)-3-(4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=O)COC2=CC=1N1C[C@H](C(N)=O)OC1=O ZXECHFBZDGVJIM-SNVBAGLBSA-N 0.000 claims description 6
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims description 6
- NMUWCDITKDTXCY-SECBINFHSA-N (5r)-3-(3-ethyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(CC)C2=CC=C1N1C[C@H](C(N)=O)OC1=O NMUWCDITKDTXCY-SECBINFHSA-N 0.000 claims description 5
- NIWCGQZRUBFWOX-CYBMUJFWSA-N (5r)-3-[4-(3,6-dihydro-2h-pyran-4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1=CCOCC1 NIWCGQZRUBFWOX-CYBMUJFWSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 229910052744 lithium Inorganic materials 0.000 claims description 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 5
- WITWMANCORVTOM-SNVBAGLBSA-N (5r)-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzothiazol-6-yl)-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C(C)C)C2=CC=C1N1C[C@H](C(N)=O)OC1=O WITWMANCORVTOM-SNVBAGLBSA-N 0.000 claims description 4
- BKSSCIZNJVZMEX-LLVKDONJSA-N (5r)-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzoxazol-6-yl)-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(C(C)C)C2=CC=C1N1C[C@H](C(N)=O)OC1=O BKSSCIZNJVZMEX-LLVKDONJSA-N 0.000 claims description 4
- UWKBPPOUKCZHEF-GFCCVEGCSA-N (5r)-2-oxo-3-(4-thiomorpholin-4-ylphenyl)-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(N2CCSCC2)C=C1 UWKBPPOUKCZHEF-GFCCVEGCSA-N 0.000 claims description 4
- MDCWSPZMNORBOW-LLVKDONJSA-N (5r)-3-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=O)CCC2=CC=1N1C[C@H](C(N)=O)OC1=O MDCWSPZMNORBOW-LLVKDONJSA-N 0.000 claims description 4
- DJUZFAHLCSKESR-LLVKDONJSA-N (5r)-3-(3,5-difluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1CCOCC1 DJUZFAHLCSKESR-LLVKDONJSA-N 0.000 claims description 4
- KDNJZJMUFCQUDR-GFCCVEGCSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-n-hydroxy-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NO)CN1C(C=C1F)=CC=C1N1CCOCC1 KDNJZJMUFCQUDR-GFCCVEGCSA-N 0.000 claims description 4
- WAGKFNIYFRFVPU-MRVPVSSYSA-N (5r)-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C)C2=CC=C1N1C[C@H](C(N)=O)OC1=O WAGKFNIYFRFVPU-MRVPVSSYSA-N 0.000 claims description 4
- NRYRVJNSXGWOMJ-SECBINFHSA-N (5r)-3-(3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(C)C2=CC=C1N1C[C@H](C(N)=O)OC1=O NRYRVJNSXGWOMJ-SECBINFHSA-N 0.000 claims description 4
- DVNYMQCCQJDHQG-SECBINFHSA-N (5r)-3-(4-methyl-3-oxo-1,4-benzothiazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=O)CSC2=CC=1N1C[C@H](C(N)=O)OC1=O DVNYMQCCQJDHQG-SECBINFHSA-N 0.000 claims description 4
- FQJBZAVZDYNYMC-PRHODGIISA-N (5r)-3-[(2r)-1-(2-hydroxyacetyl)-2-methyl-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C([C@H](N(C1=CC=2)C(=O)CO)C)C1=CC=2N1C[C@H](C(N)=O)OC1=O FQJBZAVZDYNYMC-PRHODGIISA-N 0.000 claims description 4
- UFAPAAHPPROOHH-PRHODGIISA-N (5r)-3-[(2r)-1-formyl-2-methyl-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C([C@H](N(C1=CC=2)C=O)C)C1=CC=2N1C[C@H](C(N)=O)OC1=O UFAPAAHPPROOHH-PRHODGIISA-N 0.000 claims description 4
- KQUOQZMXYWNMKZ-GFCCVEGCSA-N (5r)-3-[3,5-difluoro-4-(thian-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1C1CCSCC1 KQUOQZMXYWNMKZ-GFCCVEGCSA-N 0.000 claims description 4
- RHYNLXCUCXAWGM-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1C=CC(=O)CC1 RHYNLXCUCXAWGM-CYBMUJFWSA-N 0.000 claims description 4
- CJRFJXGGLQYNMI-SECBINFHSA-N (5r)-3-[3-fluoro-4-(5-oxo-4h-1,3,4-thiadiazin-2-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1=NNC(=O)CS1 CJRFJXGGLQYNMI-SECBINFHSA-N 0.000 claims description 4
- RYZIGHGVLLKQPY-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(oxan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1CCOCC1 RYZIGHGVLLKQPY-CYBMUJFWSA-N 0.000 claims description 4
- IBXSKLWVJHRUJN-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(thian-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1CCSCC1 IBXSKLWVJHRUJN-CYBMUJFWSA-N 0.000 claims description 4
- GNUMQVDIQCVLSO-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCN(C(=O)CO)CC1 GNUMQVDIQCVLSO-CYBMUJFWSA-N 0.000 claims description 4
- WNDLFHFRKPCLBD-LLVKDONJSA-N (5r)-3-[4-(1,1-dioxo-2,3-dihydro-1,4-thiazin-4-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1C=CS(=O)(=O)CC1 WNDLFHFRKPCLBD-LLVKDONJSA-N 0.000 claims description 4
- DXDRDTGEPCSZKE-LLVKDONJSA-N (5r)-3-[4-(2,5-dihydropyrrol-1-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1CC=CC1 DXDRDTGEPCSZKE-LLVKDONJSA-N 0.000 claims description 4
- BABHQPQBNKBUBH-OAHLLOKOSA-N (5r)-3-[4-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CC2=NC=CC=C2C1 BABHQPQBNKBUBH-OAHLLOKOSA-N 0.000 claims description 4
- MZSMUCCCNLQYJL-SECBINFHSA-N (5r)-n-methyl-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)S2)C2=C1 MZSMUCCCNLQYJL-SECBINFHSA-N 0.000 claims description 4
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- PPHTXSXTXAEQGB-LLVKDONJSA-N methyl 3-[4-[(5r)-5-carbamoyl-2-oxo-1,3-oxazolidin-3-yl]-2,6-difluorophenyl]-3-methylazetidine-1-carboxylate Chemical compound C1N(C(=O)OC)CC1(C)C1=C(F)C=C(N2C(O[C@H](C2)C(N)=O)=O)C=C1F PPHTXSXTXAEQGB-LLVKDONJSA-N 0.000 claims description 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 4
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 4
- ZBZJXHCVGLJWFG-UHFFFAOYSA-N trichloromethyl(.) Chemical compound Cl[C](Cl)Cl ZBZJXHCVGLJWFG-UHFFFAOYSA-N 0.000 claims description 4
- CJPBTUBBXNYPCV-GFCCVEGCSA-N (5r)-3-(3,5-difluoro-4-morpholin-4-ylphenyl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1N1CCOCC1 CJPBTUBBXNYPCV-GFCCVEGCSA-N 0.000 claims description 3
- PFJNWSSPBAXUQD-SNVBAGLBSA-N (5r)-3-(3-ethyl-2-oxo-1,3-benzothiazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(CC)C2=CC=C1N1C[C@H](C(=O)NC)OC1=O PFJNWSSPBAXUQD-SNVBAGLBSA-N 0.000 claims description 3
- CWTYBIOALFDHGB-SNVBAGLBSA-N (5r)-3-(3-ethyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(CC)C2=CC=C1N1C[C@H](C(N)=O)OC1=O CWTYBIOALFDHGB-SNVBAGLBSA-N 0.000 claims description 3
- DRTVZEUJGKZSRI-LLVKDONJSA-N (5r)-3-(3-ethyl-2-oxo-1,3-benzoxazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(CC)C2=CC=C1N1C[C@H](C(=O)NC)OC1=O DRTVZEUJGKZSRI-LLVKDONJSA-N 0.000 claims description 3
- RQABAESQBKRWLX-OAHLLOKOSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-n-prop-2-enyl-1,3-oxazolidine-5-carboxamide Chemical compound FC1=CC(N2C(O[C@H](C2)C(=O)NCC=C)=O)=CC=C1N1CCOCC1 RQABAESQBKRWLX-OAHLLOKOSA-N 0.000 claims description 3
- QQIXWRAJTSBLER-OAHLLOKOSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-n-propyl-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCCC)CN1C(C=C1F)=CC=C1N1CCOCC1 QQIXWRAJTSBLER-OAHLLOKOSA-N 0.000 claims description 3
- QRTUBJBBRLVBHE-CYBMUJFWSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-n-methoxy-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NOC)CN1C(C=C1F)=CC=C1N1CCOCC1 QRTUBJBBRLVBHE-CYBMUJFWSA-N 0.000 claims description 3
- URCRLDDNCLOAMA-CYBMUJFWSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1N1CCOCC1 URCRLDDNCLOAMA-CYBMUJFWSA-N 0.000 claims description 3
- IPLJXFWUBZYCKS-CYBMUJFWSA-N (5r)-3-(3-fluoro-4-pyridin-3-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(C=2C=NC=CC=2)C(F)=C1 IPLJXFWUBZYCKS-CYBMUJFWSA-N 0.000 claims description 3
- UROLCMGOKNJOLW-CYBMUJFWSA-N (5r)-3-(3-fluoro-4-pyridin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(C=2C=CN=CC=2)C(F)=C1 UROLCMGOKNJOLW-CYBMUJFWSA-N 0.000 claims description 3
- JPERMSZUEANIQN-LLVKDONJSA-N (5r)-3-[3,5-difluoro-4-(1-formyl-3-methylazetidin-3-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound FC=1C=C(N2C(O[C@H](C2)C(N)=O)=O)C=C(F)C=1C1(C)CN(C=O)C1 JPERMSZUEANIQN-LLVKDONJSA-N 0.000 claims description 3
- OJYPEHVDDYZBLI-CQSZACIVSA-N (5r)-3-[3-fluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1N1C=CC(=O)CC1 OJYPEHVDDYZBLI-CQSZACIVSA-N 0.000 claims description 3
- KFWKTPVZIZYTGO-CQSZACIVSA-N (5r)-3-[3-fluoro-4-(thian-4-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1C1CCSCC1 KFWKTPVZIZYTGO-CQSZACIVSA-N 0.000 claims description 3
- QVKNLENRPNPEMA-MRXNPFEDSA-N (5r)-3-[4-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-3-fluorophenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1N1CC2=NC=CC=C2C1 QVKNLENRPNPEMA-MRXNPFEDSA-N 0.000 claims description 3
- QDBQEWHDGZHOEJ-SNVBAGLBSA-N (5r)-n-(2-fluoroethyl)-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C)C2=CC=C1N1C[C@H](C(=O)NCCF)OC1=O QDBQEWHDGZHOEJ-SNVBAGLBSA-N 0.000 claims description 3
- GXAPJUAYPFLWTE-GFCCVEGCSA-N (5r)-n-(2-fluoroethyl)-3-(4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=O)COC2=CC=1N1C[C@H](C(=O)NCCF)OC1=O GXAPJUAYPFLWTE-GFCCVEGCSA-N 0.000 claims description 3
- JJWRKIMHGCEUMX-SNVBAGLBSA-N (5r)-n-(2-hydroxyethyl)-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C)C2=CC=C1N1C[C@H](C(=O)NCCO)OC1=O JJWRKIMHGCEUMX-SNVBAGLBSA-N 0.000 claims description 3
- USCNSXWQKOQGOB-SNVBAGLBSA-N (5r)-n-ethyl-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCC)CN1C1=CC=C(N(C)C(=O)S2)C2=C1 USCNSXWQKOQGOB-SNVBAGLBSA-N 0.000 claims description 3
- ASPIDQFPXGOSBA-GFCCVEGCSA-N (5r)-n-methyl-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzoxazol-6-yl)-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C(C)C)C(=O)O2)C2=C1 ASPIDQFPXGOSBA-GFCCVEGCSA-N 0.000 claims description 3
- YEHKRBDYWNMFAJ-GFCCVEGCSA-N (5r)-n-methyl-3-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)CC2)C2=C1 YEHKRBDYWNMFAJ-GFCCVEGCSA-N 0.000 claims description 3
- YXJLHTGVTPQZOX-SNVBAGLBSA-N (5r)-n-methyl-3-(3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)O2)C2=C1 YXJLHTGVTPQZOX-SNVBAGLBSA-N 0.000 claims description 3
- CHWWDJXJGALZNF-SNVBAGLBSA-N (5r)-n-methyl-3-(4-methyl-3-oxo-1,4-benzothiazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)CS2)C2=C1 CHWWDJXJGALZNF-SNVBAGLBSA-N 0.000 claims description 3
- BDJWHUMUYLFSEP-LLVKDONJSA-N (5r)-n-methyl-3-(4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)CO2)C2=C1 BDJWHUMUYLFSEP-LLVKDONJSA-N 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 claims description 3
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 3
- 125000004306 triazinyl group Chemical group 0.000 claims description 3
- VUPABRDXCGYACW-CYBMUJFWSA-N (5r)-2-oxo-3-[4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(N2C=CC(=O)CC2)C=C1 VUPABRDXCGYACW-CYBMUJFWSA-N 0.000 claims description 2
- YWZJCWNONYMQIH-SECBINFHSA-N (5r)-3-(2,2-difluoro-4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=O)C(F)(F)OC2=CC=1N1C[C@H](C(N)=O)OC1=O YWZJCWNONYMQIH-SECBINFHSA-N 0.000 claims description 2
- MBMYESFCZXOCFX-SNVBAGLBSA-N (5r)-3-(2,2-difluoro-4-methyl-3-oxo-1,4-benzoxazin-7-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C)C(=O)C(F)(F)O2)C2=C1 MBMYESFCZXOCFX-SNVBAGLBSA-N 0.000 claims description 2
- WZGPVZLVJWXTLZ-CYBMUJFWSA-N (5r)-3-(2-formyl-1,3,4,5-tetrahydro-2-benzazepin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(CN(CCC2)C=O)C2=C1 WZGPVZLVJWXTLZ-CYBMUJFWSA-N 0.000 claims description 2
- KIFPXSWRHLZPRM-CQSZACIVSA-N (5r)-3-(2-formyl-1,3,4,5-tetrahydro-2-benzazepin-7-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(CN(CCC2)C=O)C2=C1 KIFPXSWRHLZPRM-CQSZACIVSA-N 0.000 claims description 2
- UJXLGKPWPSYMAO-MRVPVSSYSA-N (5r)-3-(3-ethyl-4-fluoro-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(CC)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O UJXLGKPWPSYMAO-MRVPVSSYSA-N 0.000 claims description 2
- WDFGRFQXNVXCIK-SECBINFHSA-N (5r)-3-(3-ethyl-4-fluoro-2-oxo-1,3-benzothiazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(CC)C2=C(F)C=C1N1C[C@H](C(=O)NC)OC1=O WDFGRFQXNVXCIK-SECBINFHSA-N 0.000 claims description 2
- KXLFRCMTVKFXSQ-SECBINFHSA-N (5r)-3-(3-ethyl-4-fluoro-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(CC)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O KXLFRCMTVKFXSQ-SECBINFHSA-N 0.000 claims description 2
- HUKOONNMVLZCLA-SNVBAGLBSA-N (5r)-3-(3-ethyl-4-fluoro-2-oxo-1,3-benzoxazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(CC)C2=C(F)C=C1N1C[C@H](C(=O)NC)OC1=O HUKOONNMVLZCLA-SNVBAGLBSA-N 0.000 claims description 2
- OWYDTUXQHUNOID-CYBMUJFWSA-N (5r)-3-(3-formyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(CCN(CC2)C=O)C2=C1 OWYDTUXQHUNOID-CYBMUJFWSA-N 0.000 claims description 2
- ZHYROMRIZGXOSN-CQSZACIVSA-N (5r)-3-(3-formyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(CCN(CC2)C=O)C2=C1 ZHYROMRIZGXOSN-CQSZACIVSA-N 0.000 claims description 2
- OZEPAARJWXEJIN-SECBINFHSA-N (5r)-3-(4-fluoro-2-oxo-3-propan-2-yl-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C(C)C)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O OZEPAARJWXEJIN-SECBINFHSA-N 0.000 claims description 2
- QRUFMCZLXWGMSH-SNVBAGLBSA-N (5r)-3-(4-fluoro-2-oxo-3-propan-2-yl-1,3-benzothiazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C(C)C)C(=O)S2)C2=C1 QRUFMCZLXWGMSH-SNVBAGLBSA-N 0.000 claims description 2
- IQWGDUWNWKVEEN-SNVBAGLBSA-N (5r)-3-(4-fluoro-2-oxo-3-propan-2-yl-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(C(C)C)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O IQWGDUWNWKVEEN-SNVBAGLBSA-N 0.000 claims description 2
- UKRXPEAVVKZTNL-LLVKDONJSA-N (5r)-3-(4-fluoro-2-oxo-3-propan-2-yl-1,3-benzoxazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C(C)C)C(=O)O2)C2=C1 UKRXPEAVVKZTNL-LLVKDONJSA-N 0.000 claims description 2
- GRDXHMKGPWSGPF-SSDOTTSWSA-N (5r)-3-(4-fluoro-3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2SC(=O)N(C)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O GRDXHMKGPWSGPF-SSDOTTSWSA-N 0.000 claims description 2
- NNKYYBCUCYNVEM-MRVPVSSYSA-N (5r)-3-(4-fluoro-3-methyl-2-oxo-1,3-benzothiazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C)C(=O)S2)C2=C1 NNKYYBCUCYNVEM-MRVPVSSYSA-N 0.000 claims description 2
- NUZHYTLBLZEQNG-MRVPVSSYSA-N (5r)-3-(4-fluoro-3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C2OC(=O)N(C)C2=C(F)C=C1N1C[C@H](C(N)=O)OC1=O NUZHYTLBLZEQNG-MRVPVSSYSA-N 0.000 claims description 2
- HNPLAXYMRQAUST-SECBINFHSA-N (5r)-3-(4-fluoro-3-methyl-2-oxo-1,3-benzoxazol-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C)C(=O)O2)C2=C1 HNPLAXYMRQAUST-SECBINFHSA-N 0.000 claims description 2
- CPFQRZBIICTUNK-SECBINFHSA-N (5r)-3-(4-methyl-3-sulfanylidene-1,4-benzothiazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C2N(C)C(=S)CSC2=CC=1N1C[C@H](C(N)=O)OC1=O CPFQRZBIICTUNK-SECBINFHSA-N 0.000 claims description 2
- XZYXQESZFQAFRM-MRVPVSSYSA-N (5r)-3-(5-fluoro-4-methyl-3-oxo-1,4-benzothiazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C(F)=C2N(C)C(=O)CSC2=CC=1N1C[C@H](C(N)=O)OC1=O XZYXQESZFQAFRM-MRVPVSSYSA-N 0.000 claims description 2
- RUNIBIWOVOPTSA-SECBINFHSA-N (5r)-3-(5-fluoro-4-methyl-3-oxo-1,4-benzothiazin-7-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C)C(=O)CS2)C2=C1 RUNIBIWOVOPTSA-SECBINFHSA-N 0.000 claims description 2
- IRQDJICAGLWNKO-SECBINFHSA-N (5r)-3-(5-fluoro-4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C(F)=C2N(C)C(=O)COC2=CC=1N1C[C@H](C(N)=O)OC1=O IRQDJICAGLWNKO-SECBINFHSA-N 0.000 claims description 2
- DPHQVHZEGVMYQM-SNVBAGLBSA-N (5r)-3-(5-fluoro-4-methyl-3-oxo-1,4-benzoxazin-7-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C)C(=O)CO2)C2=C1 DPHQVHZEGVMYQM-SNVBAGLBSA-N 0.000 claims description 2
- SZGSXBHHFKMEAT-SNVBAGLBSA-N (5r)-3-(8-fluoro-1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C(F)=C2N(C)C(=O)CCC2=CC=1N1C[C@H](C(N)=O)OC1=O SZGSXBHHFKMEAT-SNVBAGLBSA-N 0.000 claims description 2
- HVYJVJGGLXRKPA-LLVKDONJSA-N (5r)-3-(8-fluoro-1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(N(C)C(=O)CC2)C2=C1 HVYJVJGGLXRKPA-LLVKDONJSA-N 0.000 claims description 2
- CYKKTHSKKBEKGO-CYBMUJFWSA-N (5r)-3-[2-(2-hydroxyacetyl)-1,3,4,5-tetrahydro-2-benzazepin-7-yl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(CN(CCC2)C(=O)CO)C2=C1 CYKKTHSKKBEKGO-CYBMUJFWSA-N 0.000 claims description 2
- NLPLDVOGZWCKEM-CQSZACIVSA-N (5r)-3-[2-(2-hydroxyacetyl)-1,3,4,5-tetrahydro-2-benzazepin-7-yl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(CN(CCC2)C(=O)CO)C2=C1 NLPLDVOGZWCKEM-CQSZACIVSA-N 0.000 claims description 2
- FGPXVQBWCSAZLP-GFCCVEGCSA-N (5r)-3-[3,5-difluoro-4-(1-formyl-3-methylazetidin-3-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(C2(C)CN(C2)C=O)C(F)=C1 FGPXVQBWCSAZLP-GFCCVEGCSA-N 0.000 claims description 2
- PJEOEJUBMVOCCF-LLVKDONJSA-N (5r)-3-[3,5-difluoro-4-(1-imino-1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1CCS(=N)(=O)CC1 PJEOEJUBMVOCCF-LLVKDONJSA-N 0.000 claims description 2
- SINDJTCEVXDDKF-GFCCVEGCSA-N (5r)-3-[3,5-difluoro-4-(1-imino-1-oxo-1,4-thiazinan-4-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1N1CCS(=N)(=O)CC1 SINDJTCEVXDDKF-GFCCVEGCSA-N 0.000 claims description 2
- OGWDEVZZOSDAHJ-GFCCVEGCSA-N (5r)-3-[3,5-difluoro-4-(1-methylimino-1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1CS(=NC)(=O)CCN1C1=C(F)C=C(N2C(O[C@H](C2)C(N)=O)=O)C=C1F OGWDEVZZOSDAHJ-GFCCVEGCSA-N 0.000 claims description 2
- CUQYQLRBNOYYGE-CYBMUJFWSA-N (5r)-3-[3,5-difluoro-4-(1-methylimino-1-oxo-1,4-thiazinan-4-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1N1CCS(=O)(=NC)CC1 CUQYQLRBNOYYGE-CYBMUJFWSA-N 0.000 claims description 2
- ULWADQJJGRUNFC-GFCCVEGCSA-N (5r)-3-[3,5-difluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1N1C=CC(=O)CC1 ULWADQJJGRUNFC-GFCCVEGCSA-N 0.000 claims description 2
- REDYZROCMGSTQC-CQSZACIVSA-N (5r)-3-[3,5-difluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-n-ethyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCC)CN1C(C=C1F)=CC(F)=C1N1C=CC(=O)CC1 REDYZROCMGSTQC-CQSZACIVSA-N 0.000 claims description 2
- YMEXXOOHJUPCFN-CYBMUJFWSA-N (5r)-3-[3,5-difluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1N1C=CC(=O)CC1 YMEXXOOHJUPCFN-CYBMUJFWSA-N 0.000 claims description 2
- SCDRIVUYGBNXMD-ZIAGYGMSSA-N (5r)-3-[3,5-difluoro-4-[1-[(2s)-2-hydroxy-3-(oxo-$l^{5}-phosphanylidyne)propanoyl]-3,6-dihydro-2h-pyridin-4-yl]phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1C1=CCN(C(=O)[C@H](O)C#P=O)CC1 SCDRIVUYGBNXMD-ZIAGYGMSSA-N 0.000 claims description 2
- FDJDVQBIFQGZQD-HUUCEWRRSA-N (5r)-3-[3,5-difluoro-4-[1-[(2s)-2-hydroxy-3-(oxo-$l^{5}-phosphanylidyne)propanoyl]-3,6-dihydro-2h-pyridin-4-yl]phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1C1=CCN(C(=O)[C@H](O)C#P=O)CC1 FDJDVQBIFQGZQD-HUUCEWRRSA-N 0.000 claims description 2
- PHIUQBRDVQHLSF-CYBMUJFWSA-N (5r)-3-[3-(2-hydroxyacetyl)-1,2,4,5-tetrahydro-3-benzazepin-7-yl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(CCN(CC2)C(=O)CO)C2=C1 PHIUQBRDVQHLSF-CYBMUJFWSA-N 0.000 claims description 2
- WZOZSVFAVGZQTI-CQSZACIVSA-N (5r)-3-[3-(2-hydroxyacetyl)-1,2,4,5-tetrahydro-3-benzazepin-7-yl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(CCN(CC2)C(=O)CO)C2=C1 WZOZSVFAVGZQTI-CQSZACIVSA-N 0.000 claims description 2
- DINCCWKPBRLZBJ-GFCCVEGCSA-N (5r)-3-[3-fluoro-4-(1-formyl-3-methylazetidin-3-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C=1C=C(N2C(O[C@H](C2)C(N)=O)=O)C=C(F)C=1C1(C)CN(C=O)C1 DINCCWKPBRLZBJ-GFCCVEGCSA-N 0.000 claims description 2
- BFCYCWXUPMUIKV-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(1-formyl-3-methylazetidin-3-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(C2(C)CN(C2)C=O)C(F)=C1 BFCYCWXUPMUIKV-CYBMUJFWSA-N 0.000 claims description 2
- XGTDXKXTPWAGJK-GFCCVEGCSA-N (5r)-3-[3-fluoro-4-(1-imino-1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCS(=N)(=O)CC1 XGTDXKXTPWAGJK-GFCCVEGCSA-N 0.000 claims description 2
- JYHVUZNBUFYCEK-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(1-imino-1-oxo-1,4-thiazinan-4-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1N1CCS(=N)(=O)CC1 JYHVUZNBUFYCEK-CYBMUJFWSA-N 0.000 claims description 2
- LOLZBSQOTSFWNZ-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(1-methylimino-1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1CS(=NC)(=O)CCN1C1=CC=C(N2C(O[C@H](C2)C(N)=O)=O)C=C1F LOLZBSQOTSFWNZ-CYBMUJFWSA-N 0.000 claims description 2
- ZYMYEJZPKILYFR-CQSZACIVSA-N (5r)-3-[3-fluoro-4-(1-methylimino-1-oxo-1,4-thiazinan-4-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1N1CCS(=O)(=NC)CC1 ZYMYEJZPKILYFR-CQSZACIVSA-N 0.000 claims description 2
- UHNHRWWLANSNFS-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-(4-hydroxyimino-2,3-dihydropyridin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1C=CC(=NO)CC1 UHNHRWWLANSNFS-CYBMUJFWSA-N 0.000 claims description 2
- XBZWCAGFNPJAMO-HUUCEWRRSA-N (5r)-3-[3-fluoro-4-[1-[(2s)-2-hydroxy-3-(oxo-$l^{5}-phosphanylidyne)propanoyl]-3,6-dihydro-2h-pyridin-4-yl]phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1C1=CCN(C(=O)[C@H](O)C#P=O)CC1 XBZWCAGFNPJAMO-HUUCEWRRSA-N 0.000 claims description 2
- WGOPRXGMVLHDRW-HZPDHXFCSA-N (5r)-3-[3-fluoro-4-[1-[(2s)-2-hydroxy-3-(oxo-$l^{5}-phosphanylidyne)propanoyl]-3,6-dihydro-2h-pyridin-4-yl]phenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC=C1C1=CCN(C(=O)[C@H](O)C#P=O)CC1 WGOPRXGMVLHDRW-HZPDHXFCSA-N 0.000 claims description 2
- QTZDPVIMVDPSEF-GFCCVEGCSA-N (5r)-3-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC(F)=C1C1=CCSCC1 QTZDPVIMVDPSEF-GFCCVEGCSA-N 0.000 claims description 2
- JQMIXARXMAGQCC-CYBMUJFWSA-N (5r)-3-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3,5-difluorophenyl]-n-methyl-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C(C=C1F)=CC(F)=C1C1=CCSCC1 JQMIXARXMAGQCC-CYBMUJFWSA-N 0.000 claims description 2
- ABEMHOHHWQOSBC-OAHLLOKOSA-N (5r)-n-(2-fluoroethyl)-2-oxo-3-[4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCCF)CN1C1=CC=C(N2C=CC(=O)CC2)C=C1 ABEMHOHHWQOSBC-OAHLLOKOSA-N 0.000 claims description 2
- MXSAYKUOHZQIBR-OAHLLOKOSA-N (5r)-n-ethyl-2-oxo-3-[4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCC)CN1C1=CC=C(N2C=CC(=O)CC2)C=C1 MXSAYKUOHZQIBR-OAHLLOKOSA-N 0.000 claims description 2
- RSJRBZLCUVVKNO-OAHLLOKOSA-N (5r)-n-ethyl-3-[3-fluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NCC)CN1C(C=C1F)=CC=C1N1C=CC(=O)CC1 RSJRBZLCUVVKNO-OAHLLOKOSA-N 0.000 claims description 2
- YCRTYFWSLRXJEV-LLVKDONJSA-N (5r)-n-methyl-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzothiazol-6-yl)-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N(C(C)C)C(=O)S2)C2=C1 YCRTYFWSLRXJEV-LLVKDONJSA-N 0.000 claims description 2
- GXVHBPXZIJAATJ-CQSZACIVSA-N (5r)-n-methyl-2-oxo-3-[4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC=C(N2C=CC(=O)CC2)C=C1 GXVHBPXZIJAATJ-CQSZACIVSA-N 0.000 claims description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 2
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 claims description 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 2
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 2
- 101100294103 Caenorhabditis elegans nhr-31 gene Proteins 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical group CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 claims description 2
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- IWURKKQULNDEEN-GFCCVEGCSA-N methyl 3-[2,6-difluoro-4-[(5r)-5-(methylcarbamoyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-3-methylazetidine-1-carboxylate Chemical compound O=C1O[C@@H](C(=O)NC)CN1C1=CC(F)=C(C2(C)CN(C2)C(=O)OC)C(F)=C1 IWURKKQULNDEEN-GFCCVEGCSA-N 0.000 claims description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 2
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000005505 thiomorpholino group Chemical group 0.000 claims description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims 2
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 433
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 247
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 230
- 238000002360 preparation method Methods 0.000 description 206
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 182
- 239000000203 mixture Substances 0.000 description 161
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 160
- 230000002829 reductive effect Effects 0.000 description 136
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 123
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 122
- 239000000243 solution Substances 0.000 description 116
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 110
- 235000019439 ethyl acetate Nutrition 0.000 description 108
- 238000006243 chemical reaction Methods 0.000 description 74
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 70
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 69
- 239000002904 solvent Substances 0.000 description 63
- 239000012267 brine Substances 0.000 description 58
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 58
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 57
- 239000011541 reaction mixture Substances 0.000 description 56
- 239000000741 silica gel Substances 0.000 description 55
- 229910002027 silica gel Inorganic materials 0.000 description 55
- 239000000543 intermediate Substances 0.000 description 52
- 239000007787 solid Substances 0.000 description 51
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 45
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 45
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 44
- 238000005160 1H NMR spectroscopy Methods 0.000 description 42
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 40
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 35
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 34
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 33
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 32
- 239000012074 organic phase Substances 0.000 description 31
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
- 239000000725 suspension Substances 0.000 description 29
- DYBINGBQLVCRNI-MRXNPFEDSA-N butyl (5r)-2-oxo-3-(4-thiomorpholin-4-ylphenyl)-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N2CCSCC2)C=C1 DYBINGBQLVCRNI-MRXNPFEDSA-N 0.000 description 28
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 26
- 238000001914 filtration Methods 0.000 description 25
- 239000012043 crude product Substances 0.000 description 24
- 238000000746 purification Methods 0.000 description 24
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 23
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 22
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 22
- 239000003480 eluent Substances 0.000 description 22
- 239000010410 layer Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 235000002639 sodium chloride Nutrition 0.000 description 22
- 238000003756 stirring Methods 0.000 description 22
- 239000002253 acid Substances 0.000 description 21
- 239000003814 drug Substances 0.000 description 21
- 239000012044 organic layer Substances 0.000 description 21
- 239000003054 catalyst Substances 0.000 description 20
- 239000000706 filtrate Substances 0.000 description 20
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 19
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 19
- 239000007788 liquid Substances 0.000 description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 18
- 239000011259 mixed solution Substances 0.000 description 17
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- MCVFFRWZNYZUIJ-UHFFFAOYSA-M lithium;trifluoromethanesulfonate Chemical compound [Li+].[O-]S(=O)(=O)C(F)(F)F MCVFFRWZNYZUIJ-UHFFFAOYSA-M 0.000 description 16
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 16
- 235000019341 magnesium sulphate Nutrition 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 14
- 239000002775 capsule Substances 0.000 description 14
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 14
- 238000004587 chromatography analysis Methods 0.000 description 13
- 150000003462 sulfoxides Chemical class 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 13
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 229910021529 ammonia Inorganic materials 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 238000001665 trituration Methods 0.000 description 12
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 11
- 150000001414 amino alcohols Chemical class 0.000 description 11
- 239000008194 pharmaceutical composition Substances 0.000 description 11
- 238000011176 pooling Methods 0.000 description 11
- 238000010898 silica gel chromatography Methods 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- 235000019270 ammonium chloride Nutrition 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000969 carrier Substances 0.000 description 9
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 9
- 238000004440 column chromatography Methods 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000000546 pharmaceutical excipient Substances 0.000 description 9
- 239000000651 prodrug Substances 0.000 description 9
- 229940002612 prodrug Drugs 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- SPKQRZHKGJHLFW-CYBMUJFWSA-N butyl (5r)-3-(3-ethyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N(CC)C(=O)S2)C2=C1 SPKQRZHKGJHLFW-CYBMUJFWSA-N 0.000 description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 8
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000008273 gelatin Substances 0.000 description 7
- 229920000159 gelatin Polymers 0.000 description 7
- 235000019322 gelatine Nutrition 0.000 description 7
- 235000011852 gelatine desserts Nutrition 0.000 description 7
- YKNYRRVISWJDSR-GSVOUGTGSA-N methyl (2r)-oxirane-2-carboxylate Chemical compound COC(=O)[C@H]1CO1 YKNYRRVISWJDSR-GSVOUGTGSA-N 0.000 description 7
- PEKIMFLEPUOQJW-GFCCVEGCSA-N methyl (5r)-3-(3,5-difluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC(F)=C1N1CCSCC1 PEKIMFLEPUOQJW-GFCCVEGCSA-N 0.000 description 7
- 238000007911 parenteral administration Methods 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 238000002953 preparative HPLC Methods 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 6
- OJVAMHKKJGICOG-UHFFFAOYSA-N 2,5-hexanedione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 6
- ZPOODPZCZLCUAN-UHFFFAOYSA-N 3,4-dihydro-1h-pyridin-2-one Chemical compound O=C1CCC=CN1 ZPOODPZCZLCUAN-UHFFFAOYSA-N 0.000 description 6
- CJXCQSBVVCCJCG-UHFFFAOYSA-N 3-methyl-6-nitro-1,3-benzothiazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2SC(=O)N(C)C2=C1 CJXCQSBVVCCJCG-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- FUHDWFAJHRGBNM-QGZVFWFLSA-N butyl (5r)-2-oxo-3-[4-(thian-4-yl)phenyl]-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(C2CCSCC2)C=C1 FUHDWFAJHRGBNM-QGZVFWFLSA-N 0.000 description 6
- IIDDDIKGSSYACC-MRXNPFEDSA-N butyl (5r)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C(C=C1F)=CC=C1N1CCSCC1 IIDDDIKGSSYACC-MRXNPFEDSA-N 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 125000003396 thiol group Chemical class [H]S* 0.000 description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 5
- FPNLXQSOWBNXCN-UHFFFAOYSA-N 6-amino-3-methyl-1,3-benzoxazol-2-one Chemical compound C1=C(N)C=C2OC(=O)N(C)C2=C1 FPNLXQSOWBNXCN-UHFFFAOYSA-N 0.000 description 5
- QITPMSSAFSZYOP-UHFFFAOYSA-N 6-nitro-3h-1,3-benzothiazol-2-one Chemical class C1=C([N+]([O-])=O)C=C2SC(O)=NC2=C1 QITPMSSAFSZYOP-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000007868 Raney catalyst Substances 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- LSTHXEKOIMMYML-GFCCVEGCSA-N butyl (5r)-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N(C)C(=O)S2)C2=C1 LSTHXEKOIMMYML-GFCCVEGCSA-N 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- ZBWBUOBLVLLVSY-MRVPVSSYSA-N (5R)-3-(3-methyl-2-oxo-1,3-benzothiazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylic acid Chemical compound C1=C2SC(=O)N(C)C2=CC=C1N1C[C@H](C(O)=O)OC1=O ZBWBUOBLVLLVSY-MRVPVSSYSA-N 0.000 description 4
- UQPYLSOHZOWISH-GFCCVEGCSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylic acid Chemical compound O=C1O[C@@H](C(=O)O)CN1C(C=C1F)=CC=C1N1CCOCC1 UQPYLSOHZOWISH-GFCCVEGCSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- BRUZQRBVNRKLJG-UHFFFAOYSA-N 2-methylpropyl carbamate Chemical class CC(C)COC(N)=O BRUZQRBVNRKLJG-UHFFFAOYSA-N 0.000 description 4
- NXPOFLDHVSJZRH-UHFFFAOYSA-N 2-methylpropyl n-[3-fluoro-4-(thian-4-yl)phenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC=C1C1CCSCC1 NXPOFLDHVSJZRH-UHFFFAOYSA-N 0.000 description 4
- PLZYGAAUYBWQNK-UHFFFAOYSA-N 4-(1,1-dioxo-1,4-thiazinan-4-yl)-3,5-difluoroaniline Chemical compound FC1=CC(N)=CC(F)=C1N1CCS(=O)(=O)CC1 PLZYGAAUYBWQNK-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- RQXQMUUSQGCLPL-UHFFFAOYSA-N 4-thiomorpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCSCC1 RQXQMUUSQGCLPL-UHFFFAOYSA-N 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- SNQFOJYVVZVUNK-MRXNPFEDSA-N butyl (5r)-3-[3,5-difluoro-4-(thian-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C(C=C1F)=CC(F)=C1C1CCSCC1 SNQFOJYVVZVUNK-MRXNPFEDSA-N 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 238000011097 chromatography purification Methods 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000008240 homogeneous mixture Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- OVRJVKCZJCNSOW-UHFFFAOYSA-N thian-4-one Chemical compound O=C1CCSCC1 OVRJVKCZJCNSOW-UHFFFAOYSA-N 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- WLFGGJFWKXTOGJ-UHFFFAOYSA-N 2,3-dihydroindol-1-amine Chemical compound C1=CC=C2N(N)CCC2=C1 WLFGGJFWKXTOGJ-UHFFFAOYSA-N 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N 2-benzoxazolinone Chemical compound C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- JNWGSMFRONFIOK-UHFFFAOYSA-N 2-methylpropyl n-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3,5-difluorophenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC(F)=C1C1=CCSCC1 JNWGSMFRONFIOK-UHFFFAOYSA-N 0.000 description 3
- JNVNXBAPAHAIQV-UHFFFAOYSA-N 3,5-difluoro-4-thiomorpholin-4-ylaniline Chemical compound FC1=CC(N)=CC(F)=C1N1CCSCC1 JNVNXBAPAHAIQV-UHFFFAOYSA-N 0.000 description 3
- KQOIBXZRCYFZSO-UHFFFAOYSA-N 3,5-difluoroaniline Chemical compound NC1=CC(F)=CC(F)=C1 KQOIBXZRCYFZSO-UHFFFAOYSA-N 0.000 description 3
- IXECKIKGIGZUEO-UHFFFAOYSA-N 3-ethyl-6-nitro-1,3-benzothiazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2SC(=O)N(CC)C2=C1 IXECKIKGIGZUEO-UHFFFAOYSA-N 0.000 description 3
- QFGPTCRZVHKSFY-UHFFFAOYSA-N 4-(3,6-dihydro-2h-thiopyran-4-yl)-3,5-difluoroaniline Chemical compound FC1=CC(N)=CC(F)=C1C1=CCSCC1 QFGPTCRZVHKSFY-UHFFFAOYSA-N 0.000 description 3
- GRCUAQZMYNLZIR-UHFFFAOYSA-N 6-amino-3-propan-2-yl-1,3-benzothiazol-2-one Chemical compound C1=C(N)C=C2SC(=O)N(C(C)C)C2=C1 GRCUAQZMYNLZIR-UHFFFAOYSA-N 0.000 description 3
- JGYJZHYTADCWIK-UHFFFAOYSA-N 6-nitro-3h-1,3-benzoxazol-2-one Chemical class [O-][N+](=O)C1=CC=C2NC(=O)OC2=C1 JGYJZHYTADCWIK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- YLNSNVGRSIOCEU-ZCFIWIBFSA-N [(2r)-oxiran-2-yl]methyl butanoate Chemical compound CCCC(=O)OC[C@H]1CO1 YLNSNVGRSIOCEU-ZCFIWIBFSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 238000005576 amination reaction Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- JGEHYDYWPNRITN-OAHLLOKOSA-N butyl (5r)-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzoxazol-6-yl)-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N(C(C)C)C(=O)O2)C2=C1 JGEHYDYWPNRITN-OAHLLOKOSA-N 0.000 description 3
- BCYXRYBHWQWIEP-OAHLLOKOSA-N butyl (5r)-3-(3,5-difluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C(C=C1F)=CC(F)=C1N1CCSCC1 BCYXRYBHWQWIEP-OAHLLOKOSA-N 0.000 description 3
- HWRWRZKGEJIZHJ-CYBMUJFWSA-N butyl (5r)-3-(3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N(C)C(=O)O2)C2=C1 HWRWRZKGEJIZHJ-CYBMUJFWSA-N 0.000 description 3
- SQSCOQUBAWEKPK-QGZVFWFLSA-N butyl (5r)-3-[3-fluoro-4-(thian-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C(C=C1F)=CC=C1C1CCSCC1 SQSCOQUBAWEKPK-QGZVFWFLSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000005595 deprotonation Effects 0.000 description 3
- 238000010537 deprotonation reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- PFBFPLCCCCLNFC-LLVKDONJSA-N methyl (5r)-2-oxo-3-(2-oxo-3-propan-2-yl-1,3-benzothiazol-6-yl)-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N(C(C)C)C(=O)S2)C2=C1 PFBFPLCCCCLNFC-LLVKDONJSA-N 0.000 description 3
- WKHHQHILUGKVIX-SNVBAGLBSA-N methyl (5r)-3-(4-methyl-3-oxo-1,4-benzothiazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N(C)C(=O)CS2)C2=C1 WKHHQHILUGKVIX-SNVBAGLBSA-N 0.000 description 3
- FBRZGPIEXBNAOC-NOZJJQNGSA-N methyl (5r)-3-[(2r)-1-(2-hydroxyacetyl)-2-methyl-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N([C@H](C)C2)C(=O)CO)C2=C1 FBRZGPIEXBNAOC-NOZJJQNGSA-N 0.000 description 3
- FBPSBKVDOJPWNJ-CQSZACIVSA-N methyl (5r)-3-[3-fluoro-4-(thian-4-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC=C1C1CCSCC1 FBPSBKVDOJPWNJ-CQSZACIVSA-N 0.000 description 3
- BSTNQJIXFZPKKI-MRXNPFEDSA-N methyl (5r)-3-[4-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC=C1N1CC2=NC=CC=C2C1 BSTNQJIXFZPKKI-MRXNPFEDSA-N 0.000 description 3
- AHBKOHHLMLEPEM-UHFFFAOYSA-N methyl 3-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1OC(C(=O)OC)CN1C1=CC=C(N(C)C(=O)CC2)C2=C1 AHBKOHHLMLEPEM-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000012285 osmium tetroxide Substances 0.000 description 3
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 235000015320 potassium carbonate Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000005555 sulfoximide group Chemical group 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 3
- VDHNKGVVXBUCFR-UHFFFAOYSA-N trimethyl(pyridin-3-yl)stannane Chemical compound C[Sn](C)(C)C1=CC=CN=C1 VDHNKGVVXBUCFR-UHFFFAOYSA-N 0.000 description 3
- ZZIZDBJWSSJASG-ZCFIWIBFSA-N (2r)-2-methyl-2,3-dihydro-1h-indol-5-amine Chemical compound NC1=CC=C2N[C@H](C)CC2=C1 ZZIZDBJWSSJASG-ZCFIWIBFSA-N 0.000 description 2
- JGXWQBXWQPTABN-SNVBAGLBSA-N (2r)-5-(2,5-dimethylpyrrol-1-yl)-2-methyl-2,3-dihydro-1h-indole Chemical compound C([C@H](NC1=CC=2)C)C1=CC=2N1C(C)=CC=C1C JGXWQBXWQPTABN-SNVBAGLBSA-N 0.000 description 2
- VMBFENIJZPRRNW-GFCCVEGCSA-N (5R)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylic acid Chemical compound O=C1O[C@@H](C(=O)O)CN1C(C=C1F)=CC=C1N1CCSCC1 VMBFENIJZPRRNW-GFCCVEGCSA-N 0.000 description 2
- UYNQRPSGYOWXKS-CYBMUJFWSA-N (5r)-2-oxo-3-[4-(thian-4-yl)phenyl]-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=C(C2CCSCC2)C=C1 UYNQRPSGYOWXKS-CYBMUJFWSA-N 0.000 description 2
- DIDJTOBWBNSVKL-SSDOTTSWSA-N (5r)-3-(3-fluoro-4-iodophenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(I)C(F)=C1 DIDJTOBWBNSVKL-SSDOTTSWSA-N 0.000 description 2
- COFLUECJJTXILC-LJQANCHMSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-n-phenylmethoxy-1,3-oxazolidine-5-carboxamide Chemical compound FC1=CC(N2C(O[C@H](C2)C(=O)NOCC=2C=CC=CC=2)=O)=CC=C1N1CCOCC1 COFLUECJJTXILC-LJQANCHMSA-N 0.000 description 2
- NHWIOEUMJBBCOE-XWCOYVICSA-N (5r)-3-(3-fluoro-4-trimethylstannylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound C1=C(F)C([Sn](C)(C)C)=CC=C1N1C(=O)O[C@@H](C(N)=O)C1 NHWIOEUMJBBCOE-XWCOYVICSA-N 0.000 description 2
- YFTFDMKMLDPCKJ-HXUWFJFHSA-N (5r)-3-[3-fluoro-4-[4-(2-phenylmethoxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCN(C(=O)COCC=2C=CC=CC=2)CC1 YFTFDMKMLDPCKJ-HXUWFJFHSA-N 0.000 description 2
- PTTUMBGORBMNBN-UHFFFAOYSA-N 1,2,3-trifluoro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C(F)=C1 PTTUMBGORBMNBN-UHFFFAOYSA-N 0.000 description 2
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 2
- BXQNSPXDWSNUKE-UHFFFAOYSA-N 1,3-benzothiazole 1-oxide Chemical class C1=CC=C2S(=O)C=NC2=C1 BXQNSPXDWSNUKE-UHFFFAOYSA-N 0.000 description 2
- KNWCDYSKJSREAQ-UHFFFAOYSA-N 1,3-oxazolidine-2-carboxylic acid Chemical compound OC(=O)C1NCCO1 KNWCDYSKJSREAQ-UHFFFAOYSA-N 0.000 description 2
- JLTWGXIEPHGMSB-UHFFFAOYSA-N 1-(2,6-difluoro-4-nitrophenyl)-2,5-dihydropyrrole Chemical compound FC1=CC([N+](=O)[O-])=CC(F)=C1N1CC=CC1 JLTWGXIEPHGMSB-UHFFFAOYSA-N 0.000 description 2
- SSKWTVGDOBJHOP-UHFFFAOYSA-N 1-(2-fluoro-4-nitrophenyl)-2,3-dihydropyridin-4-one Chemical compound FC1=CC([N+](=O)[O-])=CC=C1N1C=CC(=O)CC1 SSKWTVGDOBJHOP-UHFFFAOYSA-N 0.000 description 2
- BMXFDVAJYBTGRC-UHFFFAOYSA-N 1-(2-fluoro-4-nitrophenyl)piperidin-4-one Chemical compound FC1=CC([N+](=O)[O-])=CC=C1N1CCC(=O)CC1 BMXFDVAJYBTGRC-UHFFFAOYSA-N 0.000 description 2
- LFNSUPKYOILNNV-UHFFFAOYSA-N 1-(3,5-difluorophenyl)-2,5-dimethylpyrrole Chemical compound CC1=CC=C(C)N1C1=CC(F)=CC(F)=C1 LFNSUPKYOILNNV-UHFFFAOYSA-N 0.000 description 2
- TWJAWARVGANIKU-UHFFFAOYSA-N 1-(4-amino-2-fluorophenyl)-2,3-dihydropyridin-4-one Chemical compound FC1=CC(N)=CC=C1N1C=CC(=O)CC1 TWJAWARVGANIKU-UHFFFAOYSA-N 0.000 description 2
- SFNVQIUVPJGWOT-UHFFFAOYSA-N 1-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3,5-difluorophenyl]-2,5-dimethylpyrrole Chemical compound CC1=CC=C(C)N1C(C=C1F)=CC(F)=C1C1=CCSCC1 SFNVQIUVPJGWOT-UHFFFAOYSA-N 0.000 description 2
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 2
- ARSAPYZAJKOTFW-UHFFFAOYSA-N 1-methyl-6-nitro-3,4-dihydroquinolin-2-one Chemical compound [O-][N+](=O)C1=CC=C2N(C)C(=O)CCC2=C1 ARSAPYZAJKOTFW-UHFFFAOYSA-N 0.000 description 2
- PAPNRQCYSFBWDI-UHFFFAOYSA-N 2,5-Dimethyl-1H-pyrrole Chemical class CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 2
- ODUZJBKKYBQIBX-UHFFFAOYSA-N 2,6-difluoroaniline Chemical compound NC1=C(F)C=CC=C1F ODUZJBKKYBQIBX-UHFFFAOYSA-N 0.000 description 2
- BILGQMBAMYCKHR-UHFFFAOYSA-N 2-(2-fluoro-4-nitrophenyl)-4h-1,3,4-thiadiazin-5-one Chemical compound FC1=CC([N+](=O)[O-])=CC=C1C1=NNC(=O)CS1 BILGQMBAMYCKHR-UHFFFAOYSA-N 0.000 description 2
- XLDAGNLDVMWBLR-UHFFFAOYSA-N 2-(4-amino-2-fluorophenyl)-4h-1,3,4-thiadiazin-5-one Chemical compound FC1=CC(N)=CC=C1C1=NNC(=O)CS1 XLDAGNLDVMWBLR-UHFFFAOYSA-N 0.000 description 2
- DOPJTDJKZNWLRB-UHFFFAOYSA-N 2-Amino-5-nitrophenol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1O DOPJTDJKZNWLRB-UHFFFAOYSA-N 0.000 description 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 2
- UJDSRXSZJCJVCS-UHFFFAOYSA-N 2-amino-5-nitrobenzenethiol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1S UJDSRXSZJCJVCS-UHFFFAOYSA-N 0.000 description 2
- NXYOCCGTKSAZSI-UHFFFAOYSA-N 2-methylpropyl n-(3,5-difluorophenyl)carbamate Chemical compound CC(C)COC(=O)NC1=CC(F)=CC(F)=C1 NXYOCCGTKSAZSI-UHFFFAOYSA-N 0.000 description 2
- RLWSHMZGSITDJU-UHFFFAOYSA-N 2-methylpropyl n-(4-bromophenyl)carbamate Chemical compound CC(C)COC(=O)NC1=CC=C(Br)C=C1 RLWSHMZGSITDJU-UHFFFAOYSA-N 0.000 description 2
- LXZBUHPSUMRNQF-UHFFFAOYSA-N 2-methylpropyl n-[3,5-difluoro-4-(4-hydroxythian-4-yl)phenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC(F)=C1C1(O)CCSCC1 LXZBUHPSUMRNQF-UHFFFAOYSA-N 0.000 description 2
- NGLNAWJEGNSZPA-UHFFFAOYSA-N 2-methylpropyl n-[3-fluoro-4-(4-hydroxythian-4-yl)phenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC=C1C1(O)CCSCC1 NGLNAWJEGNSZPA-UHFFFAOYSA-N 0.000 description 2
- OWLXTOJXSFWXIN-UHFFFAOYSA-N 2-methylpropyl n-[4-(1,1-dioxothian-4-yl)-3-fluorophenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC=C1C1CCS(=O)(=O)CC1 OWLXTOJXSFWXIN-UHFFFAOYSA-N 0.000 description 2
- FJSBTVAXYCIQBF-UHFFFAOYSA-N 2-methylpropyl n-[4-(4-hydroxythian-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC(C)C)=CC=C1C1(O)CCSCC1 FJSBTVAXYCIQBF-UHFFFAOYSA-N 0.000 description 2
- FCNMUAPZQUTXIQ-UHFFFAOYSA-N 2-methylpropyl n-[4-(thian-4-yl)phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC(C)C)=CC=C1C1CCSCC1 FCNMUAPZQUTXIQ-UHFFFAOYSA-N 0.000 description 2
- QISAUDWTBBNJIR-UHFFFAOYSA-N 2-phenylmethoxyacetyl chloride Chemical compound ClC(=O)COCC1=CC=CC=C1 QISAUDWTBBNJIR-UHFFFAOYSA-N 0.000 description 2
- ATVJJNGVPSKBGO-UHFFFAOYSA-N 3,4-dihydro-2h-thiopyran Chemical compound C1CSC=CC1 ATVJJNGVPSKBGO-UHFFFAOYSA-N 0.000 description 2
- YSZMSIBWWSWHEB-UHFFFAOYSA-N 3,5-difluoro-4-morpholin-4-ylaniline Chemical compound FC1=CC(N)=CC(F)=C1N1CCOCC1 YSZMSIBWWSWHEB-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- KASMUJRVIWHUJM-UHFFFAOYSA-N 3-ethyl-6-nitro-1,3-benzoxazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2OC(=O)N(CC)C2=C1 KASMUJRVIWHUJM-UHFFFAOYSA-N 0.000 description 2
- PJPQOKJRZYFFHH-UHFFFAOYSA-N 3-fluoro-4-(thian-4-yl)aniline Chemical compound FC1=CC(N)=CC=C1C1CCSCC1 PJPQOKJRZYFFHH-UHFFFAOYSA-N 0.000 description 2
- QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 description 2
- VUKIKMHYSUVLQB-UHFFFAOYSA-N 3-methyl-6-nitro-1,3-benzoxazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2OC(=O)N(C)C2=C1 VUKIKMHYSUVLQB-UHFFFAOYSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- LLPPBKRBTDHNRL-UHFFFAOYSA-N 4-(2,5-dihydropyrrol-1-yl)-3,5-difluoroaniline Chemical compound FC1=CC(N)=CC(F)=C1N1CC=CC1 LLPPBKRBTDHNRL-UHFFFAOYSA-N 0.000 description 2
- BQHWIHSGWDPFRE-UHFFFAOYSA-N 4-(2,6-difluoro-4-nitrophenyl)-1,4-thiazinane 1,1-dioxide Chemical compound FC1=CC([N+](=O)[O-])=CC(F)=C1N1CCS(=O)(=O)CC1 BQHWIHSGWDPFRE-UHFFFAOYSA-N 0.000 description 2
- RAXMVOYLSJCNTN-UHFFFAOYSA-N 4-(2,6-difluoro-4-nitrophenyl)thiomorpholine Chemical compound FC1=CC([N+](=O)[O-])=CC(F)=C1N1CCSCC1 RAXMVOYLSJCNTN-UHFFFAOYSA-N 0.000 description 2
- HZQGZVKUVGTJCE-UHFFFAOYSA-N 4-(2,6-difluorophenyl)-1,4-thiazinane 1,1-dioxide Chemical compound FC1=CC=CC(F)=C1N1CCS(=O)(=O)CC1 HZQGZVKUVGTJCE-UHFFFAOYSA-N 0.000 description 2
- WRCPHSAJNXTCSL-UHFFFAOYSA-N 4-methyl-7-nitro-1,4-benzothiazin-3-one Chemical compound [O-][N+](=O)C1=CC=C2N(C)C(=O)CSC2=C1 WRCPHSAJNXTCSL-UHFFFAOYSA-N 0.000 description 2
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- YDCVXLYRCGKFBR-UHFFFAOYSA-N 5-nitro-2-(propan-2-ylamino)phenol Chemical compound CC(C)NC1=CC=C([N+]([O-])=O)C=C1O YDCVXLYRCGKFBR-UHFFFAOYSA-N 0.000 description 2
- FAQSRBYRLPRXNK-UHFFFAOYSA-N 6-amino-3-ethyl-1,3-benzoxazol-2-one Chemical compound C1=C(N)C=C2OC(=O)N(CC)C2=C1 FAQSRBYRLPRXNK-UHFFFAOYSA-N 0.000 description 2
- STDGBEKVJJKVNB-UHFFFAOYSA-N 6-amino-3-methyl-1,3-benzothiazol-2-one Chemical compound C1=C(N)C=C2SC(=O)N(C)C2=C1 STDGBEKVJJKVNB-UHFFFAOYSA-N 0.000 description 2
- CPTMCHKHHPBEIO-UHFFFAOYSA-N 6-amino-3-propan-2-yl-1,3-benzoxazol-2-one Chemical compound C1=C(N)C=C2OC(=O)N(C(C)C)C2=C1 CPTMCHKHHPBEIO-UHFFFAOYSA-N 0.000 description 2
- NQMSVHWAVMTBHK-UHFFFAOYSA-N 6-nitro-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC([N+](=O)[O-])=CC=C21 NQMSVHWAVMTBHK-UHFFFAOYSA-N 0.000 description 2
- QCJVUJJQCIHQMJ-UHFFFAOYSA-N 6-nitro-3-propan-2-yl-1,3-benzothiazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2SC(=O)N(C(C)C)C2=C1 QCJVUJJQCIHQMJ-UHFFFAOYSA-N 0.000 description 2
- PCJXQVJIUFVRTH-UHFFFAOYSA-N 6-nitro-3-propan-2-yl-1,3-benzoxazol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2OC(=O)N(C(C)C)C2=C1 PCJXQVJIUFVRTH-UHFFFAOYSA-N 0.000 description 2
- MBSIQMBTBAVBSZ-UHFFFAOYSA-N 7-amino-4-methyl-1,4-benzothiazin-3-one Chemical compound NC1=CC=C2N(C)C(=O)CSC2=C1 MBSIQMBTBAVBSZ-UHFFFAOYSA-N 0.000 description 2
- JVYJTIARQJQCKK-UHFFFAOYSA-N 7-amino-4-methyl-1,4-benzoxazin-3-one Chemical compound NC1=CC=C2N(C)C(=O)COC2=C1 JVYJTIARQJQCKK-UHFFFAOYSA-N 0.000 description 2
- OOICZQBVVODNDJ-UHFFFAOYSA-N 7-nitro-4h-1,4-benzothiazin-3-one Chemical compound N1C(=O)CSC2=CC([N+](=O)[O-])=CC=C21 OOICZQBVVODNDJ-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000186367 Mycobacterium avium Species 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 241001274216 Naso Species 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical group C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GNLJSGIRSIFOOF-UHFFFAOYSA-N [1-(2-fluoro-4-nitrophenyl)-3,6-dihydro-2h-pyridin-4-yl]oxy-trimethylsilane Chemical compound C1CC(O[Si](C)(C)C)=CCN1C1=CC=C([N+]([O-])=O)C=C1F GNLJSGIRSIFOOF-UHFFFAOYSA-N 0.000 description 2
- KDQGAHHYPPBMDY-UHFFFAOYSA-N [4-(1,1-dioxo-1,4-thiazinan-4-yl)-3,5-difluorophenyl]carbamic acid Chemical compound FC1=CC(NC(=O)O)=CC(F)=C1N1CCS(=O)(=O)CC1 KDQGAHHYPPBMDY-UHFFFAOYSA-N 0.000 description 2
- IGUGLOQBLCMITB-UHFFFAOYSA-N [N].C1=CC=C2NCCC2=C1 Chemical compound [N].C1=CC=C2NCCC2=C1 IGUGLOQBLCMITB-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001503 aryl iodides Chemical class 0.000 description 2
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- LFGHHOFSKMEHJE-GOSISDBHSA-N benzyl (2r)-5-(2,5-dimethylpyrrol-1-yl)-2-methyl-2,3-dihydroindole-1-carboxylate Chemical compound C([C@H]1C)C2=CC(N3C(=CC=C3C)C)=CC=C2N1C(=O)OCC1=CC=CC=C1 LFGHHOFSKMEHJE-GOSISDBHSA-N 0.000 description 2
- ZIOJFAZSQHZMGA-GFCCVEGCSA-N benzyl (2r)-5-amino-2-methyl-2,3-dihydroindole-1-carboxylate Chemical compound C([C@H]1C)C2=CC(N)=CC=C2N1C(=O)OCC1=CC=CC=C1 ZIOJFAZSQHZMGA-GFCCVEGCSA-N 0.000 description 2
- OPWCRBOOVRSYHY-UHFFFAOYSA-N benzyl 4-[2-fluoro-4-(phenylmethoxycarbonylamino)phenyl]piperazine-1-carboxylate Chemical compound C=1C=C(N2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C(F)=CC=1NC(=O)OCC1=CC=CC=C1 OPWCRBOOVRSYHY-UHFFFAOYSA-N 0.000 description 2
- AGGAEROGPYOAGW-LJQANCHMSA-N benzyl 4-[4-[(5r)-5-carbamoyl-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl]piperazine-1-carboxylate Chemical compound O=C1O[C@@H](C(=O)N)CN1C(C=C1F)=CC=C1N1CCN(C(=O)OCC=2C=CC=CC=2)CC1 AGGAEROGPYOAGW-LJQANCHMSA-N 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- AUIBPQAPVHZGRI-OAHLLOKOSA-N butyl (5r)-3-(3,5-difluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C(C=C1F)=CC(F)=C1N1CCOCC1 AUIBPQAPVHZGRI-OAHLLOKOSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 150000005829 chemical entities Chemical class 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- LSGWSXRILNPXKJ-SCSAIBSYSA-N ethyl (2r)-oxirane-2-carboxylate Chemical compound CCOC(=O)[C@H]1CO1 LSGWSXRILNPXKJ-SCSAIBSYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 2
- 150000002642 lithium compounds Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- QJCPBFBPYYTUKE-GFCCVEGCSA-N methyl (2r)-3-[4-(1,1-dioxo-1,4-thiazinan-4-yl)-3,5-difluoroanilino]-2-hydroxypropanoate Chemical compound FC1=CC(NC[C@@H](O)C(=O)OC)=CC(F)=C1N1CCS(=O)(=O)CC1 QJCPBFBPYYTUKE-GFCCVEGCSA-N 0.000 description 2
- IUGWWDPLTAKSHY-LLVKDONJSA-N methyl (5r)-3-(4-methyl-3-oxo-1,4-benzoxazin-7-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N(C)C(=O)CO2)C2=C1 IUGWWDPLTAKSHY-LLVKDONJSA-N 0.000 description 2
- KEFWZTCCINGSGA-NOZJJQNGSA-N methyl (5r)-3-[(2r)-1-formyl-2-methyl-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N(C=O)[C@H](C)C2)C2=C1 KEFWZTCCINGSGA-NOZJJQNGSA-N 0.000 description 2
- HGNUPQJZGKBDEZ-AUUYWEPGSA-N methyl (5r)-3-[(2r)-2-methyl-1-phenylmethoxycarbonyl-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N([C@H](C)C2)C(=O)OCC=3C=CC=CC=3)C2=C1 HGNUPQJZGKBDEZ-AUUYWEPGSA-N 0.000 description 2
- DVHAGCDARSHXLY-GFCCVEGCSA-N methyl (5r)-3-[4-(1,1-dioxo-1,4-thiazinan-4-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC(F)=C1N1CCS(=O)(=O)CC1 DVHAGCDARSHXLY-GFCCVEGCSA-N 0.000 description 2
- HRBIXSYMOGXQDD-GFCCVEGCSA-N methyl (5r)-3-[4-(2,5-dihydropyrrol-1-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC(F)=C1N1CC=CC1 HRBIXSYMOGXQDD-GFCCVEGCSA-N 0.000 description 2
- YEFGZVYURYULPT-CQSZACIVSA-N methyl (5r)-3-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC=C1C1=CCSCC1 YEFGZVYURYULPT-CQSZACIVSA-N 0.000 description 2
- BBONNOYMMYIWIW-UHFFFAOYSA-N methyl 2-[c-(2-fluoro-4-nitrophenyl)-n-[(2-methylpropan-2-yl)oxycarbonylamino]carbonimidoyl]sulfanylacetate Chemical compound CC(C)(C)OC(=O)NN=C(SCC(=O)OC)C1=CC=C([N+]([O-])=O)C=C1F BBONNOYMMYIWIW-UHFFFAOYSA-N 0.000 description 2
- YJFVEQAGDFFOCA-UHFFFAOYSA-N methyl 3-(4-amino-2,6-difluorophenyl)-3-methylazetidine-1-carboxylate Chemical compound C1N(C(=O)OC)CC1(C)C1=C(F)C=C(N)C=C1F YJFVEQAGDFFOCA-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 150000003053 piperidines Chemical class 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical group O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- MDXHQYAUOUGNPW-UHFFFAOYSA-N tert-butyl n-[(2-fluoro-4-nitrobenzenecarbothioyl)amino]carbamate Chemical compound CC(C)(C)OC(=O)NNC(=S)C1=CC=C([N+]([O-])=O)C=C1F MDXHQYAUOUGNPW-UHFFFAOYSA-N 0.000 description 2
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 125000000464 thioxo group Chemical group S=* 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- RWWXHIHZFIGDPW-UHFFFAOYSA-N (2-iodophenyl) carbamate Chemical class NC(=O)OC1=CC=CC=C1I RWWXHIHZFIGDPW-UHFFFAOYSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- LJKSLKAJOIXHRY-LLVKDONJSA-N (5r)-3-(3,5-difluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylic acid Chemical group O=C1O[C@@H](C(=O)O)CN1C(C=C1F)=CC(F)=C1N1CCSCC1 LJKSLKAJOIXHRY-LLVKDONJSA-N 0.000 description 1
- IJTAJGKEGDGGBL-GFCCVEGCSA-N (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carbonyl chloride Chemical compound FC1=CC(N2C(O[C@H](C2)C(Cl)=O)=O)=CC=C1N1CCOCC1 IJTAJGKEGDGGBL-GFCCVEGCSA-N 0.000 description 1
- BYNOFGTZDYUNLO-JHJMLUEUSA-N (5r)-3-[2-(2-fluoropiperazin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxamide Chemical compound O=C1O[C@@H](C(=O)N)CN1C1=CC=CC=C1N1C(F)CNCC1 BYNOFGTZDYUNLO-JHJMLUEUSA-N 0.000 description 1
- RQCQKRQVTWJHCR-CYBMUJFWSA-N (5r)-3-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylic acid Chemical compound O=C1O[C@@H](C(=O)O)CN1C(C=C1F)=CC=C1C1=CCSCC1 RQCQKRQVTWJHCR-CYBMUJFWSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 1
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 1
- VHKPMHQDJZYGTN-UHFFFAOYSA-N 1,2,4-oxadiazole;1,2,5-oxadiazole Chemical compound C=1C=NON=1.C=1N=CON=1 VHKPMHQDJZYGTN-UHFFFAOYSA-N 0.000 description 1
- 125000004515 1,2,4-thiadiazol-3-yl group Chemical group S1N=C(N=C1)* 0.000 description 1
- 125000004516 1,2,4-thiadiazol-5-yl group Chemical group S1N=CN=C1* 0.000 description 1
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 description 1
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 description 1
- RUBQQRMAWLSCCJ-UHFFFAOYSA-N 1,2-difluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(F)=C1 RUBQQRMAWLSCCJ-UHFFFAOYSA-N 0.000 description 1
- 125000004522 1,3,4-thiadiazol-5-yl group Chemical group S1C=NN=C1* 0.000 description 1
- AXTPKYQMUDUCFW-UHFFFAOYSA-N 1,3-thiazole 1,1-dioxide Chemical compound O=S1(=O)C=CN=C1 AXTPKYQMUDUCFW-UHFFFAOYSA-N 0.000 description 1
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 description 1
- VUCWMAJEUOWLEY-UHFFFAOYSA-N 1-$l^{1}-azanylpiperidine Chemical compound [N]N1CCCCC1 VUCWMAJEUOWLEY-UHFFFAOYSA-N 0.000 description 1
- JTLAIKFGRHDNQM-UHFFFAOYSA-N 1-bromo-2-fluoroethane Chemical compound FCCBr JTLAIKFGRHDNQM-UHFFFAOYSA-N 0.000 description 1
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QXMJAMBPNHRAPD-UHFFFAOYSA-N 1-oxido-3h-oxathiazol-1-ium Chemical compound [O-][O+]1SNC=C1 QXMJAMBPNHRAPD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- KUCWUAFNGCMZDB-UHFFFAOYSA-N 2-amino-3-nitrophenol Chemical compound NC1=C(O)C=CC=C1[N+]([O-])=O KUCWUAFNGCMZDB-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- OPEGDEXACXOYKP-UHFFFAOYSA-N 2-fluoro-3-piperazin-1-ylaniline Chemical compound NC1=CC=CC(N2CCNCC2)=C1F OPEGDEXACXOYKP-UHFFFAOYSA-N 0.000 description 1
- MMWFMFZFCKADEL-UHFFFAOYSA-N 2-fluoro-4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1F MMWFMFZFCKADEL-UHFFFAOYSA-N 0.000 description 1
- YRRZGBOZBIVMJT-UHFFFAOYSA-N 2-fluoroethanamine;hydron;chloride Chemical compound Cl.NCCF YRRZGBOZBIVMJT-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- HAFGRUIZARYXRO-UHFFFAOYSA-N 2-methylpropyl n-(3-fluoro-4-iodophenyl)carbamate Chemical compound CC(C)COC(=O)NC1=CC=C(I)C(F)=C1 HAFGRUIZARYXRO-UHFFFAOYSA-N 0.000 description 1
- XKZLTQHXNIIOAK-UHFFFAOYSA-N 2-methylpropyl n-[3,5-difluoro-4-(thian-4-yl)phenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC(F)=C1C1CCSCC1 XKZLTQHXNIIOAK-UHFFFAOYSA-N 0.000 description 1
- RVGUBBSEUVHGNN-UHFFFAOYSA-N 2-methylpropyl n-[4-(3,6-dihydro-2h-thiopyran-4-yl)-3-fluorophenyl]carbamate Chemical compound FC1=CC(NC(=O)OCC(C)C)=CC=C1C1=CCSCC1 RVGUBBSEUVHGNN-UHFFFAOYSA-N 0.000 description 1
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- PEVHDVZBCTYSKM-UHFFFAOYSA-N 2h-thiopyran-4-ol Chemical compound OC1=CCSC=C1 PEVHDVZBCTYSKM-UHFFFAOYSA-N 0.000 description 1
- YMMHAIJRFWRDMG-UHFFFAOYSA-N 3,4,4a,5-tetrahydro-1h-quinolin-2-one Chemical compound C1C=CC=C2NC(=O)CCC21 YMMHAIJRFWRDMG-UHFFFAOYSA-N 0.000 description 1
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 1
- NWWJFMCCTZLKNT-UHFFFAOYSA-N 3,4-dihydro-2h-thiazine Chemical class C1CC=CSN1 NWWJFMCCTZLKNT-UHFFFAOYSA-N 0.000 description 1
- FLSFZMRKWKUTFM-UHFFFAOYSA-N 3,5-difluoro-4-(thian-4-yl)aniline Chemical compound FC1=CC(N)=CC(F)=C1C1CCSCC1 FLSFZMRKWKUTFM-UHFFFAOYSA-N 0.000 description 1
- GTDYKIMZCQLUNT-UHFFFAOYSA-N 3-(3,4-dihydro-2h-pyridin-1-yl)-1,3-oxazolidin-2-one Chemical class O=C1OCCN1N1C=CCCC1 GTDYKIMZCQLUNT-UHFFFAOYSA-N 0.000 description 1
- FQGIBHQUVCGEAC-UHFFFAOYSA-N 3-Fluoro-4-morpholinoaniline Chemical compound FC1=CC(N)=CC=C1N1CCOCC1 FQGIBHQUVCGEAC-UHFFFAOYSA-N 0.000 description 1
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- XWGJVQLPRBNUNS-UHFFFAOYSA-N 3-fluoro-4-thiomorpholin-4-ylaniline Chemical compound FC1=CC(N)=CC=C1N1CCSCC1 XWGJVQLPRBNUNS-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- JVQIKJMSUIMUDI-UHFFFAOYSA-N 3-pyrroline Chemical compound C1NCC=C1 JVQIKJMSUIMUDI-UHFFFAOYSA-N 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- QWSQNLKNOPXCKY-UHFFFAOYSA-N 3h-1,2,4-dithiazole 1-oxide Chemical compound O=S1SCN=C1 QWSQNLKNOPXCKY-UHFFFAOYSA-N 0.000 description 1
- KWIVRAVCZJXOQC-UHFFFAOYSA-N 3h-oxathiazole Chemical compound N1SOC=C1 KWIVRAVCZJXOQC-UHFFFAOYSA-N 0.000 description 1
- MHCRLDZZHOVFEE-UHFFFAOYSA-N 4-(4-aminophenyl)morpholin-3-one Chemical compound C1=CC(N)=CC=C1N1C(=O)COCC1 MHCRLDZZHOVFEE-UHFFFAOYSA-N 0.000 description 1
- VTMGMMPHJFAIDX-UHFFFAOYSA-N 4-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-3-fluoroaniline Chemical compound FC1=CC(N)=CC=C1N1CC2=NC=CC=C2C1 VTMGMMPHJFAIDX-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- FYTRDWNKMKCQSH-UHFFFAOYSA-N 4-[[dimethyl(oxo)-$l^{6}-sulfanylidene]amino]benzonitrile Chemical compound CS(C)(=O)=NC1=CC=C(C#N)C=C1 FYTRDWNKMKCQSH-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- VLVCDUSVTXIWGW-UHFFFAOYSA-N 4-iodoaniline Chemical compound NC1=CC=C(I)C=C1 VLVCDUSVTXIWGW-UHFFFAOYSA-N 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- ZBHRAYSDUNQXKV-UHFFFAOYSA-N 4-methyl-7-nitro-1,4-benzoxazin-3-one Chemical compound [O-][N+](=O)C1=CC=C2N(C)C(=O)COC2=C1 ZBHRAYSDUNQXKV-UHFFFAOYSA-N 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- XQIRIYJOVQEBDL-UHFFFAOYSA-N 4h-1,2-benzothiazin-3-one Chemical compound C1=CC=C2SNC(=O)CC2=C1 XQIRIYJOVQEBDL-UHFFFAOYSA-N 0.000 description 1
- HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical compound C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 description 1
- JUIVJWBDXPKTJB-UHFFFAOYSA-N 5-oxo-5-phenyl-5$l^{6}-thia-2,4-diazabicyclo[4.4.0]deca-1(10),4,6,8-tetraene-3-thione Chemical group N=1C(=S)NC2=CC=CC=C2S=1(=O)C1=CC=CC=C1 JUIVJWBDXPKTJB-UHFFFAOYSA-N 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- ZLWWYKPNQBCOKF-INIZCTEOSA-N 6-[[(3s)-4-amino-3-[(6-amino-4-methylpyridin-2-yl)methoxy]butoxy]methyl]-4-methylpyridin-2-amine Chemical compound CC1=CC(N)=NC(COCC[C@@H](CN)OCC=2N=C(N)C=C(C)C=2)=C1 ZLWWYKPNQBCOKF-INIZCTEOSA-N 0.000 description 1
- NZXJETHXSNAQGR-UHFFFAOYSA-N 6-amino-3-ethyl-1,3-benzothiazol-2-one Chemical compound C1=C(N)C=C2SC(=O)N(CC)C2=C1 NZXJETHXSNAQGR-UHFFFAOYSA-N 0.000 description 1
- QLUFBCVWKTWKBF-UHFFFAOYSA-N 6-nitro-1,3-benzothiazole Chemical compound [O-][N+](=O)C1=CC=C2N=CSC2=C1 QLUFBCVWKTWKBF-UHFFFAOYSA-N 0.000 description 1
- XZOUOLRPLKUECD-UHFFFAOYSA-N 6-nitro-1,3-benzothiazole 1-oxide Chemical compound [O-][N+](=O)C1=CC=C2N=CS(=O)C2=C1 XZOUOLRPLKUECD-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- XOWBYBWBWMGAKG-UHFFFAOYSA-N C[SnH2]C1=CC=NC=C1 Chemical compound C[SnH2]C1=CC=NC=C1 XOWBYBWBWMGAKG-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 238000006824 Eschweiler-Clarke methylation reaction Methods 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical class [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- VEXQTVKQUUSBOD-UHFFFAOYSA-N ON=S(=O)=O Chemical compound ON=S(=O)=O VEXQTVKQUUSBOD-UHFFFAOYSA-N 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000748245 Villanova Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- AGRMSONEJGKOQO-UHFFFAOYSA-K [Li+].[Li+].[Li+].CS([O-])(=O)=O.CS([O-])(=O)=O.CS([O-])(=O)=O Chemical compound [Li+].[Li+].[Li+].CS([O-])(=O)=O.CS([O-])(=O)=O.CS([O-])(=O)=O AGRMSONEJGKOQO-UHFFFAOYSA-K 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-FIBGUPNXSA-N acetonitrile-d3 Chemical compound [2H]C([2H])([2H])C#N WEVYAHXRMPXWCK-FIBGUPNXSA-N 0.000 description 1
- RAFKCLFWELPONH-UHFFFAOYSA-N acetonitrile;dichloromethane Chemical compound CC#N.ClCCl RAFKCLFWELPONH-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- CWNKMHIETKEBCA-UHFFFAOYSA-N alpha-Ethylaminohexanophenone Chemical compound CCCCC(NCC)C(=O)C1=CC=CC=C1 CWNKMHIETKEBCA-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 150000001539 azetidines Chemical class 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000005872 benzooxazolyl group Chemical group 0.000 description 1
- DWDZYAWYNKMKDZ-GOSISDBHSA-N benzyl (2r)-2-methyl-5-(phenylmethoxycarbonylamino)-2,3-dihydroindole-1-carboxylate Chemical compound C([C@H](N(C1=CC=2)C(=O)OCC=3C=CC=CC=3)C)C1=CC=2NC(=O)OCC1=CC=CC=C1 DWDZYAWYNKMKDZ-GOSISDBHSA-N 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- XKGUZGHMWUIYDR-UHFFFAOYSA-N benzyl n-(3-fluoro-4-morpholin-4-ylphenyl)carbamate Chemical compound C=1C=C(N2CCOCC2)C(F)=CC=1NC(=O)OCC1=CC=CC=C1 XKGUZGHMWUIYDR-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-P bis(1h-imidazol-3-ium-3-yl)methanone Chemical compound C1=CN=C[NH+]1C(=O)[NH+]1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-P 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- PDIRPVPNNLOAKW-ZCFIWIBFSA-N butyl (2r)-oxirane-2-carboxylate Chemical compound CCCCOC(=O)[C@H]1CO1 PDIRPVPNNLOAKW-ZCFIWIBFSA-N 0.000 description 1
- BEDZPJTYYUIWHJ-CQSZACIVSA-N butyl (5r)-3-(3-ethyl-2-oxo-1,3-benzoxazol-6-yl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCCCC)CN1C1=CC=C(N(CC)C(=O)O2)C2=C1 BEDZPJTYYUIWHJ-CQSZACIVSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- FXORZKOZOQWVMQ-UHFFFAOYSA-L dichloropalladium;triphenylphosphane Chemical compound Cl[Pd]Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 FXORZKOZOQWVMQ-UHFFFAOYSA-L 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- KNKSUPJXMOAWAC-UHFFFAOYSA-N dipropan-2-yl 2,6-dimethyl-4-thiophen-2-yl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CC(C)OC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CS1 KNKSUPJXMOAWAC-UHFFFAOYSA-N 0.000 description 1
- 229940042397 direct acting antivirals cyclic amines Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RBBXSUBZFUWCAV-UHFFFAOYSA-N ethenyl hydrogen sulfite Chemical compound OS(=O)OC=C RBBXSUBZFUWCAV-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- MPCPJKAPOGWZEV-CQSZACIVSA-N ethyl (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OCC)CN1C(C=C1F)=CC=C1N1CCOCC1 MPCPJKAPOGWZEV-CQSZACIVSA-N 0.000 description 1
- FDWMYEAYYQHOJQ-UHFFFAOYSA-N ethyl 2-cyano-2-(2,6-difluoro-4-nitrophenyl)propanoate Chemical compound CCOC(=O)C(C)(C#N)C1=C(F)C=C([N+]([O-])=O)C=C1F FDWMYEAYYQHOJQ-UHFFFAOYSA-N 0.000 description 1
- MIHRVXYXORIINI-UHFFFAOYSA-N ethyl 2-cyanopropionate Chemical compound CCOC(=O)C(C)C#N MIHRVXYXORIINI-UHFFFAOYSA-N 0.000 description 1
- FYUBSBMPJMDCCY-UHFFFAOYSA-N ethyl 3-[3-fluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1OC(C(=O)OCC)CN1C(C=C1F)=CC=C1N1C=CC(=O)CC1 FYUBSBMPJMDCCY-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical compound OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006077 hetero Diels-Alder cycloaddition reaction Methods 0.000 description 1
- 238000007074 heterocyclization reaction Methods 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- SXWRTZOXMUOJER-UHFFFAOYSA-N hydron;piperidin-4-one;chloride;hydrate Chemical compound O.Cl.O=C1CCNCC1 SXWRTZOXMUOJER-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- NAHAZYALLPATSD-FOIQADDNSA-N methyl (5r)-3-[(2r)-2-methyl-1-(2-phenylmethoxyacetyl)-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C1=CC=C(N([C@H](C)C2)C(=O)COCC=3C=CC=CC=3)C2=C1 NAHAZYALLPATSD-FOIQADDNSA-N 0.000 description 1
- IGZKWZIWBNPUAS-HXUWFJFHSA-N methyl (5r)-3-[3-fluoro-4-(4-phenylmethoxycarbonylpiperazin-1-yl)phenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC=C1N1CCN(C(=O)OCC=2C=CC=CC=2)CC1 IGZKWZIWBNPUAS-HXUWFJFHSA-N 0.000 description 1
- CUTXOZLBARFTQV-GFCCVEGCSA-N methyl (5r)-3-[4-(1,1-dioxo-2,3-dihydro-1,4-thiazin-4-yl)-3,5-difluorophenyl]-2-oxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1O[C@@H](C(=O)OC)CN1C(C=C1F)=CC(F)=C1N1C=CS(=O)(=O)CC1 CUTXOZLBARFTQV-GFCCVEGCSA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- BLLFVUPNHCTMSV-UHFFFAOYSA-N methyl nitrite Chemical compound CON=O BLLFVUPNHCTMSV-UHFFFAOYSA-N 0.000 description 1
- YHLVIDQQTOMBGN-UHFFFAOYSA-N methyl prop-2-enyl carbonate Chemical compound COC(=O)OCC=C YHLVIDQQTOMBGN-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- ZVBHSXDRKZILGK-UHFFFAOYSA-N n-phenyl-3,4-dihydro-2h-pyridin-1-amine Chemical class C1CCC=CN1NC1=CC=CC=C1 ZVBHSXDRKZILGK-UHFFFAOYSA-N 0.000 description 1
- QQSRDPPYXVPRHQ-UHFFFAOYSA-N n-phenylazetidin-1-amine Chemical compound C1CCN1NC1=CC=CC=C1 QQSRDPPYXVPRHQ-UHFFFAOYSA-N 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- LQNUZADURLCDLV-IDEBNGHGSA-N nitrobenzene Chemical group [O-][N+](=O)[13C]1=[13CH][13CH]=[13CH][13CH]=[13CH]1 LQNUZADURLCDLV-IDEBNGHGSA-N 0.000 description 1
- 150000005181 nitrobenzenes Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 1
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 206010033072 otitis externa Diseases 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 1
- 125000005880 oxathiolanyl group Chemical group 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical compound NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical class O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000011937 reductive transformation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- XZPVPNZTYPUODG-UHFFFAOYSA-M sodium;chloride;dihydrate Chemical compound O.O.[Na+].[Cl-] XZPVPNZTYPUODG-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 229940066769 systemic antihistamines substituted alkylamines Drugs 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical class CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 1
- YGNGABUJMXJPIJ-UHFFFAOYSA-N thiatriazole Chemical compound C1=NN=NS1 YGNGABUJMXJPIJ-UHFFFAOYSA-N 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- YCBWXJZXFUKDPU-UHFFFAOYSA-N trimethyl(pyridin-4-yl)stannane Chemical compound C[Sn](C)(C)C1=CC=NC=C1 YCBWXJZXFUKDPU-UHFFFAOYSA-N 0.000 description 1
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35949502P | 2002-02-25 | 2002-02-25 | |
PCT/US2003/003125 WO2003072553A1 (en) | 2002-02-25 | 2003-02-24 | N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20040717A2 true HRP20040717A2 (en) | 2005-02-28 |
Family
ID=27766097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040717A HRP20040717A2 (en) | 2002-02-25 | 2004-08-06 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
Country Status (36)
Country | Link |
---|---|
US (1) | US6919329B2 (uk) |
EP (1) | EP1478629B1 (uk) |
JP (1) | JP2005524660A (uk) |
KR (1) | KR100613532B1 (uk) |
CN (1) | CN1639135A (uk) |
AP (1) | AP1902A (uk) |
AR (1) | AR038536A1 (uk) |
AT (1) | ATE342258T1 (uk) |
AU (1) | AU2003210807A1 (uk) |
BR (1) | BR0307924A (uk) |
CA (1) | CA2476038A1 (uk) |
CO (1) | CO5611128A2 (uk) |
CY (1) | CY1105797T1 (uk) |
DE (1) | DE60308998T2 (uk) |
DK (1) | DK1478629T3 (uk) |
EA (1) | EA007490B1 (uk) |
EC (1) | ECSP045245A (uk) |
ES (1) | ES2271615T3 (uk) |
GE (1) | GEP20074198B (uk) |
HR (1) | HRP20040717A2 (uk) |
IS (1) | IS7376A (uk) |
MA (1) | MA27180A1 (uk) |
MX (1) | MXPA04008205A (uk) |
MY (1) | MY135233A (uk) |
NO (1) | NO20044062L (uk) |
NZ (1) | NZ534521A (uk) |
OA (1) | OA12779A (uk) |
PL (1) | PL372461A1 (uk) |
PT (1) | PT1478629E (uk) |
SI (1) | SI1478629T1 (uk) |
TN (1) | TNSN04163A1 (uk) |
TW (1) | TW200305568A (uk) |
UA (1) | UA80112C2 (uk) |
WO (1) | WO2003072553A1 (uk) |
YU (1) | YU72804A (uk) |
ZA (1) | ZA200406362B (uk) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
AU2003265090A1 (en) | 2002-10-10 | 2004-05-04 | Pharmacia & Upjohn Comapny LLC | Antimicrobial 1-aryl dihydropyridone compounds |
WO2004089943A1 (en) * | 2003-04-09 | 2004-10-21 | Pharmacia & Upjohn Company Llc | Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues |
US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
PT1656370E (pt) | 2003-06-03 | 2012-11-29 | Rib X Pharmaceuticals Inc | Compostos biaril-heterocíclicos e métodos de os produzir e de os utilizar |
WO2005005399A1 (en) * | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Oxazolidinone antibiotics and derivatives thereof |
KR20060113625A (ko) | 2003-07-02 | 2006-11-02 | 머크 앤드 캄파니 인코포레이티드 | 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체 |
TW200526626A (en) | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
TW200526649A (en) | 2003-12-17 | 2005-08-16 | Rib X Pharmaceuticals Inc | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
MX2007001568A (es) * | 2004-08-06 | 2007-04-16 | Pharmacia & Upjohn Co Llc | Oxindol oxazolidinonas como agentes antibacterianos. |
WO2006056877A2 (en) * | 2004-11-29 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Diazepine oxazolidinones as antibacterial agents |
EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
EP1853586B1 (en) | 2005-02-18 | 2013-07-24 | AstraZeneca AB | Antibacterial piperidine derivatives |
AU2006231919A1 (en) | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
US7592335B2 (en) | 2005-04-15 | 2009-09-22 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
ATE496914T1 (de) | 2005-06-08 | 2011-02-15 | Rib X Pharmaceuticals Inc | Verfahren zur synthese von triazolen |
DE602006010702D1 (de) | 2005-06-29 | 2010-01-07 | Pharmacia & Upjohn Co Llc | Homomorpholinoxazolidinone als antibakterielle mittel |
CA2614105A1 (en) * | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
WO2007004032A1 (en) * | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidiones containing cyclobutane as antibacterial agents |
CN101389627A (zh) * | 2005-12-23 | 2009-03-18 | 阿斯利康(瑞典)有限公司 | 具有抗菌作用的吡咯并吡啶、吡咯并嘧啶和吡咯并氮杂 |
WO2007088478A1 (en) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Indazole oxazolidinones as antibacterial agents |
CN101460495B (zh) * | 2006-03-31 | 2013-08-14 | 财团法人乙卯研究所 | 具有杂环的化合物 |
EP2062878A4 (en) * | 2006-08-30 | 2010-09-08 | Shionogi & Co | HYDRAZINE AMIDE DERIVATIVE |
US8088777B2 (en) * | 2006-08-30 | 2012-01-03 | Shionogi & Co., Ltd. | Urea derivative |
CN101720325B (zh) * | 2007-08-06 | 2013-04-24 | 上海盟科药业有限公司 | 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮 |
EP2233484A3 (en) | 2007-10-02 | 2012-04-04 | Research Foundation Itsuu Laboratory | Oxazolidinone derivatives having a 7-membered heterocyclic ring |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
BRPI0917394A2 (pt) * | 2008-08-18 | 2019-09-24 | Univ Yale | moduladores de mif |
US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
US8841306B2 (en) | 2008-11-20 | 2014-09-23 | Panacea Biotec Ltd. | Antimicrobials |
AU2010210627B2 (en) * | 2009-02-03 | 2016-03-03 | Merck Sharp & Dohme Llc | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
AU2010264027B9 (en) | 2009-06-26 | 2013-06-13 | Panacea Biotec Ltd. | Novel azabicyclohexanes |
CN103140483B (zh) | 2010-07-15 | 2015-06-24 | 拜耳知识产权有限责任公司 | 作为杀虫剂的新杂环化合物 |
UA112897C2 (uk) | 2012-05-09 | 2016-11-10 | Байєр Фарма Акцієнгезелльшафт | Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань |
WO2015127316A1 (en) | 2014-02-21 | 2015-08-27 | Micurx Pharmaceuticals, Inc. | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration |
IL275443B (en) * | 2018-02-26 | 2022-07-01 | Sumitomo Chemical Co | Production method for an oxazolidinan compound |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
US5043443A (en) | 1988-07-29 | 1991-08-27 | Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives |
US5182403A (en) | 1988-09-15 | 1993-01-26 | The Upjohn Company | Substituted 3(5'indazolyl) oxazolidin-2-ones |
US5225565A (en) | 1988-09-15 | 1993-07-06 | The Upjohn Company | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones |
US5164510A (en) | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
EP0417044A3 (en) | 1989-09-07 | 1991-06-12 | Ciba-Geigy Ag | Oxazolidinones and thiones as plantgrowth regulators |
US5231188A (en) | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
CA2119556C (en) | 1991-11-01 | 2004-07-06 | Michael Robert Barbachyn | Substituted aryl- and heteroaryl-phenyloxazolidinones |
SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
CA2136324A1 (en) | 1992-07-08 | 1994-01-20 | Steven Joseph Brickner | 5'-indolinyl oxazolidinones useful against mycobacterium tuberculosis |
ATE161833T1 (de) | 1992-12-08 | 1998-01-15 | Upjohn Co | Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel |
MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
US5652238A (en) | 1993-11-22 | 1997-07-29 | Pharmacia & Upjohn Company | Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
JPH0873455A (ja) | 1994-03-15 | 1996-03-19 | Upjohn Co:The | オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物 |
DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
DE4425609A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
DE4429461A1 (de) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
PT788498E (pt) | 1994-10-26 | 2002-02-28 | Upjohn Co | Compostos antimicrobianos de feniloxazolidinona |
ES2193201T3 (es) | 1994-11-15 | 2003-11-01 | Upjohn Co | Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica. |
EP0807112B1 (en) | 1995-02-03 | 2001-09-05 | PHARMACIA & UPJOHN COMPANY | Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
ES2162047T3 (es) | 1995-05-11 | 2001-12-16 | Upjohn Co | Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico. |
RU2175324C2 (ru) | 1995-09-01 | 2001-10-27 | Фармация Энд Апджон Компани | Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами |
DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
DE69716925T2 (de) | 1996-08-21 | 2003-09-11 | Pharmacia & Upjohn Co., Kalamazoo | Isoxazoline derivate und ihre verwendung als antimikroben |
ATE293609T1 (de) | 1997-05-30 | 2005-05-15 | Upjohn Co | Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität |
DE19730847A1 (de) | 1997-07-18 | 1999-01-28 | Bayer Ag | Tricyclisch substituierte Oxazolidinone |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
US6083967A (en) | 1997-12-05 | 2000-07-04 | Pharmacia & Upjohn Company | S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
DE19802239A1 (de) | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
DE19802235A1 (de) | 1998-01-22 | 1999-07-29 | Bayer Ag | Mit tricyclischen Indolen substituierte Oxazolidinone |
EP1049682A1 (en) | 1998-01-23 | 2000-11-08 | Versicor, Inc. | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
DE19805117A1 (de) | 1998-02-09 | 1999-08-12 | Bayer Ag | Neue Oxazolidinone mit azolhaltigen Tricyclen |
TR200003595T2 (tr) | 1998-06-05 | 2001-07-23 | Astrazeneca Ab | Kimyasal bileşikler |
GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
IL144669A0 (en) | 1999-02-01 | 2002-05-23 | Upjohn Co | Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
JP2003501351A (ja) | 1999-05-27 | 2003-01-14 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌剤としての二環系オキサゾリジノン |
GB9928499D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical processes and intermediates |
PL356478A1 (en) | 1999-12-21 | 2004-06-28 | Pharmacia & Upjohn Company | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
GB0100110D0 (en) | 2001-01-04 | 2001-02-14 | Univ Leeds | Modulation of calcium channel activity |
GB0113297D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
US7049443B2 (en) * | 2001-07-12 | 2006-05-23 | Pharmacia & Upjohn Company | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
-
2003
- 2003-02-20 AR ARP030100552A patent/AR038536A1/es unknown
- 2003-02-21 MY MYPI20030608A patent/MY135233A/en unknown
- 2003-02-24 BR BR0307924-4A patent/BR0307924A/pt not_active IP Right Cessation
- 2003-02-24 NZ NZ534521A patent/NZ534521A/en unknown
- 2003-02-24 AU AU2003210807A patent/AU2003210807A1/en not_active Abandoned
- 2003-02-24 OA OA1200400221A patent/OA12779A/en unknown
- 2003-02-24 AP APAP/P/2004/003110A patent/AP1902A/en active
- 2003-02-24 EP EP03743112A patent/EP1478629B1/en not_active Expired - Lifetime
- 2003-02-24 WO PCT/US2003/003125 patent/WO2003072553A1/en active IP Right Grant
- 2003-02-24 US US10/373,286 patent/US6919329B2/en not_active Expired - Fee Related
- 2003-02-24 YU YU72804A patent/YU72804A/sh unknown
- 2003-02-24 DK DK03743112T patent/DK1478629T3/da active
- 2003-02-24 AT AT03743112T patent/ATE342258T1/de not_active IP Right Cessation
- 2003-02-24 KR KR1020047013297A patent/KR100613532B1/ko not_active IP Right Cessation
- 2003-02-24 GE GEAP8378A patent/GEP20074198B/en unknown
- 2003-02-24 CN CNA038044986A patent/CN1639135A/zh active Pending
- 2003-02-24 ES ES03743112T patent/ES2271615T3/es not_active Expired - Lifetime
- 2003-02-24 MX MXPA04008205A patent/MXPA04008205A/es active IP Right Grant
- 2003-02-24 PT PT03743112T patent/PT1478629E/pt unknown
- 2003-02-24 PL PL03372461A patent/PL372461A1/xx unknown
- 2003-02-24 SI SI200330518T patent/SI1478629T1/sl unknown
- 2003-02-24 UA UA20040807036A patent/UA80112C2/uk unknown
- 2003-02-24 JP JP2003571259A patent/JP2005524660A/ja active Pending
- 2003-02-24 CA CA002476038A patent/CA2476038A1/en not_active Abandoned
- 2003-02-24 EA EA200400893A patent/EA007490B1/ru not_active IP Right Cessation
- 2003-02-24 DE DE60308998T patent/DE60308998T2/de not_active Expired - Lifetime
- 2003-02-25 TW TW092103898A patent/TW200305568A/zh unknown
-
2004
- 2004-07-29 IS IS7376A patent/IS7376A/is unknown
- 2004-08-06 HR HR20040717A patent/HRP20040717A2/hr not_active Application Discontinuation
- 2004-08-11 ZA ZA200406362A patent/ZA200406362B/xx unknown
- 2004-08-13 CO CO04079406A patent/CO5611128A2/es not_active Application Discontinuation
- 2004-08-24 TN TNP2004000163A patent/TNSN04163A1/fr unknown
- 2004-08-24 MA MA27837A patent/MA27180A1/fr unknown
- 2004-08-25 EC EC2004005245A patent/ECSP045245A/es unknown
- 2004-09-24 NO NO20044062A patent/NO20044062L/no not_active Application Discontinuation
-
2006
- 2006-11-17 CY CY20061101682T patent/CY1105797T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20040717A2 (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
US7645781B2 (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | |
US6313307B1 (en) | Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings | |
US7049443B2 (en) | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound | |
CN101679454A (zh) | 治疗细菌感染的抗菌杂环化合物 | |
WO2005082897A1 (en) | Oxazolidinone antibacterial agents | |
US20040127530A1 (en) | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives | |
US7105547B2 (en) | Antimicrobial 1-aryl dihydropyridone compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080128 Year of fee payment: 6 |
|
OBST | Application withdrawn |